col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


579 Results       Page 1

 [1] 
Elsevier: Clinical Microbiology and Infection
  original article Date Title Authors   All Authors
1 [GO] 2024―Oct―23 Neurodevelopmental outcomes of infants after in utero exposure to SARS-CoV-2 or mRNA COVID-19 vaccine compared to unexposed infants: a COVI-PREG prospective cohort study Guillaume Favre, Rebecca L. Bromley, Matthew Bluett-Duncan, Emeline Maisonneuve, Léo Pomar, Charlotte Daire, et al. (+11)
2 [GO] 2024―Oct―09 ‘Nirmatrelvir/ritonavir treatment and risk for post-acute sequelae of COVID-19 in older Singaporeans’ - Author’s reply Liang En Wee, Jue Tao Lim, An Ting Tay, Calvin J. Chiew, Barnaby Edward Young, Betty Wong, et al. (+6)
3 [GO] 2024―Sep―27 Re: ‘Nirmatrelvir/ritonavir treatment and risk for post-acute sequelae of COVID-19 in older Singaporeans’ by Wee et al. Hinpetch Daungsupawong, Viroj Wiwanitkit
4 [GO] 2024―Aug―28 Nirmatrelvir/ritonavir treatment and risk for post-acute sequelae of COVID-19 in older Singaporeans Liang En Wee, Jue Tao Lim, An Ting Tay, Calvin J. Chiew, Barnaby Edward Young, Betty Wong, et al. (+6)
5 [GO] 2024―Aug―08 Erratum to ’TMPRSS2 inhibitors for the treatment of COVID-19 in adults: a systematic review and meta-analysis of randomized clinical trials of nafamostat and camostat mesylate’ [Clinical Microbiology and Infection 30 (2024) 743-754] María Patricia Hernández-Mitre, Susan C. Morpeth, Balasubramanian Venkatesh, Thomas E. Hills, Joshua Davis, Robert K. Mahar, et al. (+5)
6 [GO] 2024―Aug―06 ‘The efficacy of antivirals, corticosteroids, and mAbs as acute COVID treatments in reducing the incidence of long COVID’ - Author’s reply Gangqiang Sun, Ke Lin, Jingwen Ai, Wenhong Zhang
7 [GO] 2024―Jul―26 Convalescent plasma and predictors of mortality among hospitalized COVID-19 patients: a systematic review and meta-analysis Massimo Franchini, Mario Cruciani, Carlo Mengoli, Arturo Casadevall, Claudia Glingani, Michael J. Joyner, et al. (+6)
8 [GO] 2024―Jul―26 Re: ‘The efficacy of antivirals, corticosteroids, and mAbs as acute COVID treatments in reducing the incidence of long COVID’ by Sun et al. Hui Li, Xia Wang, Guangting Zeng
9 [GO] 2024―Jul―14 The efficacy of antivirals, corticosteroids, and mAbs as acute COVID treatments in reducing the incidence of long COVID: a Systematic Review and meta-analysis Gangqiang Sun, Ke Lin, Jingwen Ai, Wenhong Zhang
10 [GO] 2024―Jul―11 COVID-19 Surge During Summer 2024: The Phantom Menace? B. Davido, B. Mégarbane, P. Loubet
11 [GO] 2024―Jul―11 Quantifying the impact of COVID-19-related restrictions on antibiotic resistance Charis A. Marwick, Laura Ciaccio
12 [GO] 2024―Jun―25 Factors associated with SARS-CoV-2 testing, diagnosis and COVID-19 disease among individuals prescribed opioid-agonist treatment: a nationwide retrospective cohort study. Megan Glancy, Alan Yeung, Andrew McAuley, Norah Palmateer, Jen Bishop, Bob Taylor, et al. (+4)
13 [GO] 2024―Jun―21 Long-term cardiovascular, cerebrovascular, and thrombotic complications after SARS-CoV-2-Omicron infection: a retrospective cohort study Liang En Wee, Jue Tao Lim, An Ting Tay, Deanette Pang, Calvin J. Chiew, Yew Woon Chia, et al. (+5)
14 [GO] 2024―May―31 ‘Persistent COVID-19 in immunocompromised patients - Israeli society of infectious diseases consensus statement on diagnosis and management’ - Author’s reply Suzy E. Meijer, Yael Paran, Ana Belkin, Tal Brosh-Nissimov
15 [GO] 2024―May―29 The World Health Organization Pandemic Agreement draft: Considerations by the ESCMID Emerging Infections Task Force (EITaF) Guido Granata, Roberta Astorri, Els M. Broens, Helen Callaby, Flávia Cunha, Antonino Di Caro, et al. (+11)
16 [GO] 2024―May―21 Re: ‘Persistent COVID-19 in Immunocompromised Patients - Israeli Society of Infectious Diseases Consensus Statement on Diagnosis and Management’ by Meijer et al. Alberto Enrico Maraolo, Nicola Schiano Moriello, Ivan Gentile
17 [GO] 2024―Apr―24 An update on the anti-Spike monoclonal antibody pipeline for SARS-CoV-2 Daniele Focosi, Massimo Franchini, Arturo Casadevall, Fabrizio Maggi
18 [GO] 2024―Apr―18 Persistent COVID-19 in Immunocompromised Patients - Israeli Society of Infectious Diseases Consensus Statement on Diagnosis and Management Suzy E. Meijer, Yael Paran, Ana Belkin, Ronen Ben-Ami, Yasmin Maor, Lior Nesher, et al. (+3)
19 [GO] 2024―Mar―29 ‘Impact of the COVID-19 pandemic on antibiotic prescribing in high-prescribing primary care physicians in Switzerland’ - Author’s reply Soheila Aghlmandi, Julia Bielicki, Heiner C. Bucher
20 [GO] 2024―Mar―28 Intradermal delivery of the third dose of the mRNA-1273 SARS-CoV-2 vaccine: safety and immunogenicity of a fractional booster dose Geert V.T. Roozen, Manon L.M. Prins, Corine Prins, Jacqueline J. Janse, Heidi L.M. de Gruyter, Cilia R. Pothast, et al. (+15)
21 [GO] 2024―Mar―27 “Stuck in pandemic uncertainty: A review of the persistent Effects of COVID-19 infection in immune deficient people” Bevin Manuelpillai, Mackenzie Zendt, Emma Chang-Rabley, Emily E. Ricotta
22 [GO] 2024―Mar―23 Epidemiology of Escherichia coli bloodstream infection antimicrobial resistance trends across South West England during the first two years of the coronavirus disease 2019 pandemic response J. Stanley, B. Sullivan, A.W. Dowsey, K. Jones, C.R. Beck
23 [GO] 2024―Mar―23 Prevalence of long COVID in the general adult population according to different definitions and sociodemographic and infection characteristics. A nationwide random sampling survey in France in autumn 2022 Joël Coste, Cyrille Delpierre, Jean-Baptiste Richard, Caroline Alleaume, Anne Gallay, Sarah Tebeka, et al. (+4)
24 [GO] 2024―Mar―11 Re: ‘Impact of the COVID-19 pandemic on antibiotic prescribing in high-prescribing primary care physicians in Switzerland’ by Aghlmandi et al. Plüss-Suard Catherine, Mueller Yolanda, Plate Andreas, Senn Oliver, Kronenberg Andreas
25 [GO] 2024―Mar―11 Molecular detection of SARS-CoV-2 and other respiratory viruses in saliva and classroom air: a two winters tale Nicolas Banholzer, Pascal Bittel, Philipp Jent, Lavinia Furrer, Kathrin Zürcher, Matthias Egger, et al. (+2)
26 [GO] 2024―Mar―08 Pandemic preparedness beyond COVID-19: what we know, what we do, and what we don’t Juan M. Pericàs
27 [GO] 2024―Feb―09 Major cardiovascular events after COVID-19 in people with HIV Raquel Martín-Iguacel, Sergio Moreno-Fornés, Andreu Bruguera, Jordi Aceitón, Daniel Kwakye Nomah, Ana González-Cordón, et al. (+32)
28 [GO] 2024―Feb―08 Information bias for case-definitions and mortality between, and within studies over time undermines our understanding of COVID-19 transmission and disease severity Daniel Pan, Hidekazu Nishimura, Julian W. Tang
29 [GO] 2024―Feb―06 Vaccination and the risk of post-acute sequelae after COVID-19 In the Omicron-predominant period Kyungmin Huh, Young-Eun Kim, Gi Hwan Bae, Jong Youn Moon, Ji-Man Kang, Jacob Lee, et al. (+3)
30 [GO] 2024―Feb―06 Safeguarding COVID-19 Vaccines: Establishing the Safety of Novel Vaccine Platforms David Shasha
31 [GO] 2024―Feb―06 TMPRSS2 inhibitors for the treatment of COVID-19 in adults: a systematic review and meta-analysis of nafamostat and camostat mesylate randomised clinical trials Hernández-Mitre María Patricia, Morpeth Susan, Venkatesh Balasubramanian, Hills Thomas, Davis Joshua, Mahar Robert, et al. (+5)
32 [GO] 2024―Jan―22 Solid organ transplantation in SARS-CoV-2 positive recipients: a web-survey among ESGICH members Andrea Lombardi, Paolo Grossi
33 [GO] 2024―Jan―21 Immunogenicity and safety of concomitant bivalent COVID-19 and quadrivalent influenza vaccination: Implications of immune imprinting and interference Min Joo Choi, Young Jun Yu, Jae Won Kim, Hea Jeon Ju, So Youn Shin, Yun-Jung Yang, et al. (+10)
34 [GO] 2024―Jan―05 The potential role of vagus nerve dysfunction and dysautonomia in long COVID Ili Margalit, Dafna Yahav
35 [GO] 2024―Jan―04 Choosing immunomodulating therapies for the treatment of COVID-19: Recommendations based on placebo-controlled trial evidence Daniel A. Sweeney, Suzana M. Lobo, Pedro Póvoa, Andre C. Kalil
36 [GO] 2023―Dec―29 Biomarkers of early SARS-CoV-2 infection prior to the onset of respiratory symptoms Ooiean Teng, Amy May Lin Quek, Tuong Minh Nguyen, Suqing Wang, Isabel Xue Qi Ng, Lorivie Fragata, et al. (+3)
37 [GO] 2023―Dec―22 Antibody response and risk of reinfection over two years among the first wave of COVID-19 patients Maddalena Peghin, Maria De Martino, Alvisa Palese, Stefania Chiappinotto, Federico Fonda, Valentina Gerussi, et al. (+5)
38 [GO] 2023―Dec―22 Long-term neuropsychiatric sequelae of Delta versus Omicron SARS-CoV-2 infection Liang En Wee, Jue Tao Lim, An Ting Tay, Deanette Pang, Borame Dickens, Calvin J. Chiew, et al. (+3)
39 [GO] 2023―Dec―15 Diagnostic accuracy of a point-of-care antigen test for SARS-CoV-2 and influenza in a primary care population (RAPTOR-C19) Thomas R. Fanshawe, Sharon TONNER, Philip J. Turner, Jade Cogdale, Margaret Glogowska, Simon De Lusignan, et al. (+21)
40 [GO] 2023―Dec―14 Corrigendum to “Virological and clinical rebounds of COVID-19 soon after nirmatrelvir/ritonavir discontinuation”Clin Microbiol Infect 2022 Dec;28(12):1657-1658 Guido Antonelli, Daniele Focosi, Ombretta Turriziani, Marco Tuccori, Rossella Brandi, Silvia Fillo, et al. (+3)
41 [GO] 2023―Dec―13 Comparative safety analysis of mRNA and adenoviral vector COVID-19 vaccines: a nationwide cohort study using an emulated target trial approach Min Joo Choi, Yewon Na, Hak Jun Hyun, Eliel Nham, Jin Gu Yoon, Hye Seong, et al. (+7)
42 [GO] 2023―Dec―09 Risk factors, mortality, and predictors of survival in COVID-19-associated pulmonary mucormycosis: a multicenter retrospective study from India Valliappan Muthu, Ritesh Agarwal, Shivaprakash Mandya Rudramurthy, Deepak Thangaraju, Manoj Radhakishan Shevkani, Atul K. Patel, et al. (+50)
43 [GO] 2023―Nov―22 Impact of the COVID-19 pandemic on antibiotic prescribing in high-prescribing primary care physicians in Switzerland Soheila Aghlmandi, Florian S. Halbeisen, Pascal Godet, Andri Signorell, Simon Sigrist, Ramon Saccilotto, et al. (+4)
44 [GO] 2023―Nov―08 Extracting symptoms from free-text responses using ChatGPT among COVID-19 cases in Hong Kong Wan In WEI, Cyrus Lap Kwan LEUNG, Arthur TANG, Edward B. MCNEIL, Samuel Yeung Shan WONG, Kin On KWOK
45 [GO] 2023―Nov―02 Are we neglecting MERS-CoV during COVID-19 pandemic: A need for refocusing on surveillance of the deadly MERS-CoV infection Mallhi Tauqeer, Khan Yusra Habib, Salman Muhammad, Butt Muhammad Hammad
46 [GO] 2023―Oct―20 Prevalence and risk factors for persistent symptoms after COVID-19: a systematic review and meta-analysis De Luo, Bingjie Mei, Piao Wang, Xujia Li, Xinpei Chen, Gang Wei, et al. (+3)
47 [GO] 2023―Sep―20 A SARS-CoV-2 and Influenza rapid antigen test-based hospital isolation policy awaiting RT-PCR, a prospective observational study Nathalie van der Moeren, Vivian F. Zwart, Marie Louise van Leest, Marcel Thijssen, Robbert Groenewegen, Marieke Kuipers-de Heer, et al. (+4)
48 [GO] 2023―Aug―22 Risk of Bell’s palsy following SARS-CoV-2 infection: a nationwide cohort study Hye Jun Kim, Seogsong Jeong, Jihun Song, Sun Jae Park, Yun Hwan Oh, Jaehun Jung, et al. (+2)
49 [GO] 2023―Aug―18 Corrigendum to Does SARS-CoV-2 re-infection depend on virus variant? Clin Microbiol Infect. 2021 Sep;27(9):1374-1375. Philippe Gautret, Linda Houhamdi, Nhu Ngog Nguyen, Van Thuan Hoang, Audrey Giraud-Gatineau, Didier Raoult
50 [GO] 2023―Aug―12 Waning protection after vaccination and prior infection against COVID-19-related mortality over 18 months Dominik Dietler, Fredrik Kahn, Malin Inghammar, Jonas Björk
51 [GO] 2023―Jul―28 'Short intravenous amphotericin B followed by oral posaconazole using a simple, stratified treatment approach for diabetes or COVID-19 associated rhino-orbito-cerebral mucormycosis' Author's reply Mavuto Mukaka, Abi Manesh, George M. Varghese
52 [GO] 2023―Jun―22 Amantadine for COVID-19 treatment (ACT study): a randomized, double-blinded, placebo-controlled clinical trial Nina Weis, Signe Bollerup, Jon Dissing Sund, Jakob Borg Glamann, Caroline Vinten, Louise Riger Jensen, et al. (+3)
53 [GO] 2023―Jun―20 Risk of congenital malformation following first trimester mRNA COVID-19 vaccine exposure in pregnancy: the COVI-PREG prospective cohort Guillaume Favre, Emeline Maisonneuve, Léo Pomar, Charlotte Daire, Cécile Monod, Begoña Martinez de Tejada, et al. (+34)
54 [GO] 2023―Jun―20 Short intravenous amphotericin B followed by oral posaconazole using a simple, stratified treatment approach for diabetes or COVID-19 associated rhino-orbito-cerebral mucormycosis: A prospective cohort study Abi Manesh, Emily Devasagayam, Kundakarla Bhanuprasad, Lalee Varghese, Regi Kurien, Lisa M. Cherian, et al. (+14)
55 [GO] 2023―Jun―17 Real-world effectiveness of nirmatrelvir/ritonavir against COVID-19 hospitalisations and severe COVID-19 in community-dwelling elderly Singaporeans during Omicron BA.2, BA.4/5 and XBB transmission Liang En Wee, An Ting Tay, Calvin Chiew, Barnaby Edward Young, Betty Wong, Ruth Lim, et al. (+5)
56 [GO] 2023―Jun―15 Detection of viable SARS-CoV-2 on the hands of hospitalised children with COVID-19 Meryl Haas, Paola Fürhacker, Jan Hodek, Petra Stangl, Isabelle Alon, Katharina Kainz, et al. (+13)
57 [GO] 2023―Jun―15 Adaptability of single nucleotide polymorphism (SNP)-PCR for subtyping SARS-CoV-2 and a new SNP-PCR for XBB, XBB.1.5, and B.Q.1/B.Q.1.1 Gordon Ritchie, Matthew Young, Natalie Prystajecky, Marc G. Romney, Christopher F. Lowe, Nancy Matic
58 [GO] 2023―May―24 Durability and determinants of anti-SARS-CoV-2 spike antibodies following the second and third doses of mRNA COVID-19 vaccine Shohei Yamamoto, Yusuke Oshiro, Natsumi Inamura, Takashi Nemoto, Kumi Horii, Kaori Okudera, et al. (+7)
59 [GO] 2023―May―13 Viral dynamics of SARS-CoV-2 in immunocompromised patients Andrea N. Utzon, Isik S. Johansen, Line L. Bang, Rune M. Pedersen, Thomas E. Andersen, Lone W. Madsen
60 [GO] 2023―May―13 Virus variant specific clinical performance of a SARS-CoV-2 rapid antigen test with focus on omicron VOC Linus Bornemann, Olaf Kaup, Johannes Kleideiter, Bertram Ruprecht, Annika Hoyer, Marcus Panning, et al. (+2)
61 [GO] 2023―May―12 Greater attention to flexible hospital designs and ventilated clinical facilities are a pre-requisite for coping with the next airborne pandemic Hilary Humphreys, Margreet Vos, Elisabeth Presterl, Markus Hell
62 [GO] 2023―May―09 Corrigendum to ‘In search of viable SARS-CoV-2 in the tear film: a prospective clinical study in hospitalized symptomatic patients’ Laura Leysen, Heleen Delbeke, Stefanie Desmet, Pieter-Paul Schauwvlieghe, Piet Maes, Gauthier Blanckaert, et al. (+3)
63 [GO] 2023―May―06 COVID-19 mortality among selective serotonin reuptake inhibitor users - Results from a nationwide cohort Marius Ahm Stauning, Dogukan Jesper Gür, Christian Torp-Pedersen, Jens Tingleff
64 [GO] 2023―May―06 Using machine learning to predict antibody response to SARS-CoV-2 vaccination in solid organ transplant recipients: the multicentre ORCHESTRA cohort Maddalena Giannella, Manuel Huth, Elda Righi, Jan Hasenauer, Lorenzo Marconi, Angelina Konnova, et al. (+135)
65 [GO] 2023―Apr―27 Molecular characterization of Candida auris outbreak isolates in Qatar from COVID-19 patients reveals the emergence of isolates resistant to three classes of antifungal drugs Fatma Ben Abid, Husam Salah, Sathyavathi Sundararaju, Lamya Dalil, Ayman H. Abdelwahab, Sarah Salameh, et al. (+5)
66 [GO] 2023―Apr―23 Update of ESCMID COVID-19 guidelines: diagnostic testing for SARS-CoV-2 Paraskevi C. Fragkou, Giulia De Angelis, Giulia Menchinelli, Fusun Can, Federico Garcia, Florence Morfin-Sherpa, et al. (+9)
67 [GO] 2023―Apr―20 Molnupiravir for treatment of adults with mild or moderate COVID-19: a systematic review and meta-analysis of randomised controlled trials Ya Gao, Ming Liu, Zhifan Li, Jianguo Xu, Junhua Zhang, Jinhui Tian
68 [GO] 2023―Apr―12 Evaluating the impact of a virtual outpatient care program in preventing hospitalizations, emergency department visits and mortality for patients with COVID-19: a matched cohort study Mei-Ni Belzile, Philip Lam, Adrienne K. Chan, Nisha Andany, Andrew Simor, Jose Estrada-Codecido, et al. (+8)
69 [GO] 2023―Apr―01 Efficacy and safety of selective serotonin reuptake inhibitors in COVID-19 management - Author's reply Jiawen Deng, Eesha Affan, Cristian Garcia, Kiyan Heybati, Fangwen Zhou
70 [GO] 2023―Apr―01 Implications from COVID-19 for future pandemic Global Health Governance Jeffrey V. Lazarus, Cristina Pujol Martinez, Christopher J. Kopka, Carolina Batista, Wafaa M. El-Sadr, Rocio Saenz, Ayman El-Mohandes
71 [GO] 2023―Mar―23 Detection of viable SARS-CoV-2 in retrospective analysis of aerosol samples collected from hospital rooms of patients with COVID-19 Audray Fortin, Marc Veillette, Adriana Larrotta, Yves Longtin, Caroline Duchaine, Nathalie Grandvaux
72 [GO] 2023―Mar―18 Clinical outcomes of the SARS-cov-2 omicron and delta variant: systematic review and meta-analysis of 33 studies covering 6,037,144 COVID-19 positive patients Feihong Hu, Yijie Jia, Danyan Zhao, Xuelei Fu, Wanqing Zhang, Wen Tang, et al. (+7)
73 [GO] 2023―Mar―13 COVID-19-associated mucormycosis: A systematic review and meta-analysis of 958 cases Laşin Özbek, Umur Topçu, Mehtap Manay, Buğra Han Esen, Sevval Nur Bektas, Serhat Aydın, et al. (+9)
74 [GO] 2023―Mar―01 Corrigendum to: “Development and validation of a prediction model for severe respiratory failure in hospitalized patients with SARS-CoV-2 infection: a multicentre cohort study (PREDI-CO study)” Michele Bartoletti, Maddalena Giannella, Luigia Scudeller, Sara Tedeschi, Matteo Rinaldi, Linda Bussini, et al. (+24)
75 [GO] 2023―Feb―10 Co-administration of COVID-19 and influenza vaccines Arnaud M. Didierlaurent, Paul-Henri Lambert
76 [GO] 2023―Feb―10 Practical problems and responses for SARS-CoV-2 laboratory testing during the COVID-19 pandemic Julian W. Tang, Meik Dilcher, Paul W. Bird, Jen Kok, Chun Kiat Lee, Hidekazu Nishimura, et al. (+5)
77 [GO] 2023―Feb―04 The association of neonatal SARS-CoV-2 anti-spike protein receptor-binding domain antibodies at delivery with infant COVID-19 infection under age 6 months: a prospective cohort study Lital Oz-Alkalay, Eyal Elron, Rotem Davidovits, Gabriel Chodick, Micky Osovsky, Rony Chen, Liat Ashkenazi-Hoffnung
78 [GO] 2023―Feb―04 Re: 'Efficacy and safety of selective serotonin reuptake inhibitors in COVID-19 management' by Deng et al. Guangting Zeng, Jing Liu, Shulan Liu
79 [GO] 2023―Feb―04 Community Adoption of Protective Behaviours: Pre- and Post-COVID-19 pandemic Angela Chow, Huiling Guo
80 [GO] 2023―Feb―02 Bacillus Calmette-Guérin vaccine for prevention of COVID-19 and other respiratory tract infections in older adults with comorbidities: a randomized controlled trial Eva L. Koekenbier, Konstantin Fohse, Josephine S. van de Maat, Jan Jelrik Oosterheert, Cees van Nieuwkoop, Jacobien J. Hoogerwerf, et al. (+67)
81 [GO] 2023―Jan―23 Immunologic Characterization of a Patient with Clinical and Virologic Rebound upon Nirmatrelvir/Ritonavir: the Unfortunate Epilogue of COVID-19 Giulia Marchetti, Roberta Rovito, Valeria Bono, Paola Bonara, Francesca Bai, Antonella d’Arminio Monforte
82 [GO] 2023―Jan―21 Vaccination against SARS-CoV-2 in pregnancy during the Omicron wave: the prospective cohort study of the Italian obstetric surveillance system Edoardo Corsi Decenti, Michele Antonio Salvatore, Donatella Mandolini, Serena Donati, Irene Alberi, Franco Camandona, et al. (+38)
83 [GO] 2023―Jan―18 Respiratory multiplex PCR and procalcitonin to reduce antibiotic exposure in severe SARS-CoV-2 pneumonia: a multicenter randomised controlled trial Muriel Fartoukh, Saad Nseir, Bruno Mégarbane, Yves Cohen, Antoine Lafarge, Damien Contou, et al. (+39)
84 [GO] 2023―Jan―16 Bivalent BNT162b2mRNA original/Omicron BA.4-5 booster vaccination: adverse reactions and inability to work compared to the monovalent COVID-19 booster Isabell Wagenhäuser, Julia Reusch, Alexander Gabel, Lukas B. Krone, Oliver Kurzai, Nils Petri, Manuel Krone
85 [GO] 2023―Jan―16 Efficacy and safety of selective serotonin reuptake inhibitors in COVID-19 management: A systematic review and meta-analysis Jiawen Deng, Daniel Rayner, Harikrishnaa Ba Ramaraju, Umaima Abbas, Cristian Garcia, Kiyan Heybati, et al. (+4)
86 [GO] 2023―Jan―13 A Systematic Review of Trials Currently Investigating Therapeutic Modalities for Post-Acute COVID-19 Syndrome and Registered on World Health Organization International Clinical Trials Platform Nader A. Fawzy, Bader Abou Shaar, RandM. Taha, Tarek Z. Arabi, Belal N. Sabbah, Mohamad S. Alkodaymi, et al. (+10)
87 [GO] 2023―Jan―12 Which trial do we need? Management of elderly, fragile, fully vaccinated patients hospitalized with SARS-CoV-2 infection Marius Trøseid, Jose R. Arribas
88 [GO] 2023―Jan―11 Drug-drug interactions of ritonavir-boosted SARS-cov-2 protease inhibitors in solid organ transplant recipients: experience from the initial use of lopinavir-ritonavir Gonzalez-García R, Joan-Ramon Roma, María Rodríguez-García, Natalia Arranz, Juan Ambrosioni, Marta Bodro, et al. (+14)
89 [GO] 2023―Jan―05 The controversial bond between COVID-19 and bacterial superinfections Cecilia Bonazzetti, Maddalena Giannella
90 [GO] 2022―Dec―29 Impact of vaccination on the presence and severity of symptoms of hospitalised patients with an infection by the omicron variant (B.1.1.529) of the SARS-cov-2 (subvariant BA.1) Guillaume Beraud, Laura Bouetard, Rok Civljak, Jocelyn Michon, Necla Tulek, Sophie Lejeune, et al. (+20)
91 [GO] 2022―Dec―28 Time to negative PCR conversion among high-risk patients with mild-to-moderate Omicron BA.1 and BA.2 COVID-19 treated by Sotrovimab or Nirmatrelvir Guillaume Martin-Blondel, Anne-Geneviève Marcelin, Cathia Soulié, Sofia Kaisaridi, Clovis Lusivika-Nzinga, Karen Zafilaza, et al. (+28)
92 [GO] 2022―Dec―09 Polio is back? The risk of poliomyelitis recurrence globally, and the legacy of SARS-CoV-2 pandemic Concetta Castilletti, Maria Rosaria Capobianchi
93 [GO] 2022―Dec―09 Antibiotic resistance associated with the COVID-19 pandemic: a systematic review and meta-analysis B.J. Langford, J.-P.R. Soucy, V. Leung, M. So, A.T.H. Kwan, J.S. Portnoff, et al. (+4)
94 [GO] 2022―Dec―09 Immunogenicity of COVID-19 vaccines in solid organ transplant recipients: a systematic review and meta-analysis Xinpei Chen, De Luo, Bingjie Mei, Juan Du, Xiangdong Liu, Hui Xie, et al. (+3)
95 [GO] 2022―Dec―07 Who should receive oral anti-viral therapy for SARS-CoV2 infection in the omicron era? - Choose wisely! Günter Weiss
96 [GO] 2022―Dec―01 Platform trials as the way forward in infectious disease’ clinical research: the case of COVID-19 Juan M. Pericàs, Lennie PG. Derde, Scott M. Berry
97 [GO] 2022―Dec―01 Increased Reporting of Venous and Arterial Thromboembolic events reported with Tixagevimab-Cilgavimab for COVID-19 François Montastruc, Margaux Lafaurie, Clara Flumian, Claire de Canecaude
98 [GO] 2022―Nov―26 The heavy burden of covid-19-related mortality among the elderly in Corsica, 2020-2021 Tony Gomes, Laurent Serpin, Dominique Bertei, Delphine Poitrenaud, Jean-François Cesari-Giordani, Aba Mahamat, et al. (+29)
99 [GO] 2022―Nov―19 Early antithrombotic therapy for another highly lethal viral pneumonia pandemic Xiaoming Wu, Mengqi Xiang, Haijiao Jing, Langjiao Liu, Chunli Wang, Valerie A. Novakovic, Jialan Shi
100 [GO] 2022―Nov―13 Diagnostic accuracy of SARS-CoV-2 rapid antigen self-tests in asymptomatic individuals in the Omicron period: cross sectional study Roderick P. Venekamp, Ewoud Schuit, Lotty Hooft, Irene K. Veldhuijzen, Wouter van den Bijllaardt, Suzan D. Pas, et al. (+14)
101 [GO] 2022―Nov―12 Real-life evaluation of a rapid antigen test (DPP® SARS-CoV-2 antigen) for COVID-19 diagnosis of primary healthcare patients, in the context of the omicron-dominant wave in Brazil Matheus Filgueira Bezerra, Lilian Caroliny Amorim Silva, Rômulo Pessoa-e-Silva, Gisele Lino, Soares,Filipe Zimmer Dezordi, et al. (+10)
102 [GO] 2022―Nov―11 'The unique COVID-19 presentation of patients with B cell depletion' - Author’s reply Ana Belkin, Dafna Yahav
103 [GO] 2022―Nov―04 B-cell malignancies and COVID-19: a narrative review David Luque-Paz, Pierre Sesques, Florent Wallet, Emmanuel Bachy, Florence Ader, V. Alcazer, et al. (+17)
104 [GO] 2022―Nov―04 COVID-19 convalescent plasma therapy through the lens of the third year of the pandemic
105 [GO] 2022―Nov―03 Fighting stigma and discrimination against COVID-19 in China Ming Zheng
106 [GO] 2022―Nov―03 Performance of point-of care molecular and antigen-based tests for SARS-CoV-2: a living systematic review and meta-analysis Paraskevi C. Fragkou, Charalampos D. Moschopoulos, Dimitra Dimopoulou, David S.Y. Ong, Konstantina Dimopoulou, Philipp P. Nelson, et al. (+10)
107 [GO] 2022―Oct―28 Effect of COVID-19 infection and pandemic period on healthcare-associated infections acquired in intensive care units Alain Lepape, Anaïs Machut, Cedric Bretonniere, Arnaud Friggeri, Charles-Hervé Vacheron, Anne Savey, et al. (+174)
108 [GO] 2022―Oct―27 Re: 'The unique COVID-19 presentation of patients with B cell depletion' by Belkin et al Elena Múñez-Rubio, Jorge Calderón-Parra, Ana Fernández-Cruz, Víctor Moreno-Torres, Silvia Blanco-Alonso, Antonio Ramos-Martínez
109 [GO] 2022―Oct―20 Tocilizumab versus baricitinib in hospitalized patients with severe COVID-19: an open label, randomized controlled trial. Theodoros Karampitsakos, Ourania Papaioannou, Panagiota Tsiri, Matthaios Katsaras, Andreas Katsimpris, Andreas P. Kalogeropoulos, et al. (+13)
110 [GO] 2022―Oct―17 Successful immunomodulators for treatment of COVID-19 have opened the pathway for comparative trials Jason C. Gallagher, Rebecca L. Morgan
111 [GO] 2022―Oct―17 Serum neutralization of SARS-CoV-2 Omicron sublineages BA.1 and BA.2, and cellular immune responses 3 months after booster vaccination Enagnon Kazali Alidjinou, Julie Demaret, Bénédicte Corroyer-Simovic, Fanny Vuotto, Sophie Miczek, Julien Labreuche, et al. (+19)
112 [GO] 2022―Oct―14 One-month humoral response following two or three doses of mRNA Covid-19 vaccines as primary vaccination in specific populations in France: first results from the ANRS0001S COV-POPART cohort Paul Loubet, Linda Wittkop, Laetitia Ninove, Mathieu Chalouni, Benoit Barrou, Jean-Yves Blay, et al. (+20)
113 [GO] 2022―Oct―06 The unique COVID-19 presentation of patients with B cell depletion - definition of the “persistent inflammatory seronegative COVID” (PISC) Ana Belkin, Avshalom Leibowitz, Liat Shargian, Dafna Yahav
114 [GO] 2022―Oct―04 ‘Remdesivir for the treatment of COVID-19' - Author's reply Todd C. Lee, Emily G. McDonald
115 [GO] 2022―Oct―04 Re: 'Remdesivir for the Treatment of COVID-19' by Lee et al. Alessia Beccacece, Tommaso Ascoli Bartoli, Emanuele Nicastri
116 [GO] 2022―Oct―01 Cross-protective humoural immunity to coronaviruses from SARS-CoV-2-naïve sera of children with Kawasaki disease Tzu-Yi Lin, Yu-Lin Lee, Kun-Lang Wu, Ming-Chun Yang, Chi-Nan Huang, Chun-Min Fu, et al. (+4)
117 [GO] 2022―Sep―30 Prevalence of post-acute COVID-19 symptoms twelve months after hospitalisation in participants retained in follow-up: analyses stratified by gender from a large prospective cohort Jade GHOSN, Delphine BACHELET, Marine LIVROZET, Minerva CERVANTES-GONZALEZ, Julien POISSY, François GOEHRINGER, et al. (+20)
118 [GO] 2022―Sep―30 Predictors of survival in elderly patients with COVID-19 admitted to the hospital: derivation and validation of the FLAMINCOV score Tiseo Giusy, Margalit Ili, Ripa Marco, Green Hefziba, Prendki Virginie, Riccardi Niccolò, et al. (+10)
119 [GO] 2022―Sep―15 SARS-CoV-2 RNA loads in breakthrough COVID-19 caused by the Delta and Omicron variants Paula de Michelena, Ignacio Torres, Enric-Cuevas Ferrando, Beatriz Olea, Fernando González-Candelas, Gloria Sánchez, David Navarro
120 [GO] 2022―Sep―10 A Prospective Population-Level Validation of the Abbott ID NOW SARS-CoV-2 Device Implemented in Multiple Settings for Testing Asymptomatic and Symptomatic Individuals William Stokes, Allison A. Venner, Emily Buss, Graham Tipples, Byron M. Berenger
121 [GO] 2022―Sep―10 Evaluating the Efficacy and Safety of SpikoGen®, an Advax-CpG55.2-adjuvanted SARS-CoV-2 Spike Protein Vaccine: A Phase 3 Randomized Placebo-Controlled Trial Payam Tabarsi, Nassim Anjidani, Ramin Shahpari, Masoud Mardani, Araz Sabzvari, Babak Yazdani, et al. (+6)
122 [GO] 2022―Sep―05 The disease burden of Delta and Omicron variants of SARS-CoV-2 in a Predominantly Vaccinated and healthy cohort Parham Sendi, Mattia Branca, Annina Elisabeth Büchi, Nadja Widmer, Aaron J. Tande, Peter Gowland
123 [GO] 2022―Aug―28 Assessing the impact of COVID-19 on mortality: A population-based matched case-control study Adi Turjeman, Eytan Wirtheim, Itamar Poran, Leonard Leibovici
124 [GO] 2022―Aug―28 Effectiveness of the first-generation SARS-CoV-2 mRNA vaccines against the omicron variant Noa Dagan, Noam Barda
125 [GO] 2022―Aug―24 Virus variant specific clinical performance of SARS-CoV-2 rapid antigen tests in point-of-care use, November 2020 to January 2022 Isabell Wagenhäuser, Kerstin Knies, Daniela Hofmann, Vera Rauschenberger, Michael Eisenmann, Julia Reusch, et al. (+27)
126 [GO] 2022―Aug―24 ESCMID COVID-19 guidelines: update on treatment for patients with mild/moderate disease Michele Bartoletti, Ozlem Azap, Aleksandra Barac, Linda Bussini, Onder Ergonul, Robert Krause, et al. (+8)
127 [GO] 2022―Aug―23 Outpatient convalescent plasma therapy for high-risk patients with early COVID-19. A randomized placebo-controlled trial Arvind Gharbharan, Carlijn Jordans, Lisa Zwaginga, Grigorios Papageorgiou, Nan van Geloven, Peter van Wijngaarden, et al. (+53)
128 [GO] 2022―Aug―23 Blockbuster effect of COVID-19 on the impact factor of infectious disease journals Alexis Maillard, Tristan Delory
129 [GO] 2022―Aug―05 Daily tenofovir disoproxil fumarate/emtricitabine and hydroxychloroquine for pre-exposure prophylaxis of COVID-19: a double-blind placebo controlled randomized trial in healthcare workers R. Polo, X. García-Albéniz, C. Terán, M. Morales, D. Rial-Crestelo, M.A. Garcinuño, et al. (+182)
130 [GO] 2022―Aug―01 Pre-exposure prophylaxis with tixagevimab and cilgavimab (Evusheld©) for COVID-19 among 1112 severely immunocompromised patients Yann Nguyen, Adrien Flahault, Nathalie Chavarot, Cléa Melenotte, Morgane Cheminant, Paul Deschamps, et al. (+22)
131 [GO] 2022―Jul―20 SARS-CoV-2 Exposures of Healthcare Workers and Acquisition of COVID-19 J. Leal, T. Jefferson, J. Conly
132 [GO] 2022―Jul―19 Effect of Tocilizumab, Sarilumab, and Baricitinib on Mortality Among Patients Hospitalized for COVID-19 Treated with Corticosteroids: A Systematic Review and Meta-Analysis Arthur M. Albuquerque, Igor Eckert, Lucas Tramujas, Guillaume Butler-Laporte, Emily G. McDonald, James M. Brophy, Todd C. Lee
133 [GO] 2022―Jul―19 SARS-CoV-2 Antigen Tests Predict Infectivity based on viral culture: comparison of antigen, PCR viral load, and viral culture testing on a large Sample Cohort James E. Kirby, Stefan Riedel, Sanjucta Dutta, Ramy Arnaout, Annie Cheng, Sarah Ditelberg, et al. (+3)
134 [GO] 2022―Jul―16 Heterologous COVID-19 vaccination as a strategy to accelerate mass immunization Vibeke Klastrup, Nina Breinholt Stærke, Ole Schmeltz Søgaard
135 [GO] 2022―Jul―16 Duration of infectious shedding of SARS-CoV-2 omicron variant and its relation with symptoms Şiran Keske, Gülen Güney Esken, Cansel Vatansever, Yeşim Beşli, Zeynep Ece Kuloğlu, Zeliş Nergiz, et al. (+6)
136 [GO] 2022―Jul―14 Long title: Exhaled SARS-CoV-2 RNA viral load kinetics measured by facemask sampling associates with household transmission Daniel Pan, Caroline M. Williams, Jonathan Decker, Eve Fletcher, Shirley Sze, Sara Assadi, et al. (+6)
137 [GO] 2022―Jul―04 'Early administration of tocilizumab in hospitalized COVID-19 patients with elevated inflammatory markers; COVIDSTORM' - Author’s reply N. Broman, T. Feuth, J. Oksi
138 [GO] 2022―Jul―04 The impact of COVID-19 vaccination program in the Republic of San Marino: focus on effectiveness of Gam-COVID-Vac Giuseppe Tonnara, Pierluca Piselli, Claudia Cimaglia, Massimo Arlotti, Elena Sacchini, Samanta Manoni, et al. (+8)
139 [GO] 2022―Jul―02 Virological and clinical rebounds of COVID-19 soon after nirmatrelvir/ritonavir discontinuation Guido Antonelli, Daniele Focosi, Ombretta Turriziani, Marco Tuccori, Rossella Brandi, Silvia Fillo, et al. (+3)
140 [GO] 2022―Jul―02 Evidence of co-infections during Delta and Omicron SARS-CoV-2 variants co-circulation through prospective screening and sequencing Patricia Combes, Maxime Bisseux, Antonin Bal, Pierre Marin, Justine Latour, Christine Archimbaud, et al. (+10)
141 [GO] 2022―Jun―30 Impact of vaccination on the symptoms of hospitalised patients with SARS-CoV-2 delta variant (B.1.617.1) infection Epaulard Olivier, Abgrall Sophie, Lefebvre Maeva, Faucher Jean-François, Michon Jocelyn, Frentiu Emilia, et al. (+9)
142 [GO] 2022―Jun―29 Cumulative seroprevalence among healthcare workers after the first wave of the COVID-19 pandemic in El Salvador, Central America Yu Nakagama, Maria-Virginia Rodriguez-Funes, Rhina Dominguez, Katherine-Sofia Candray-Medina, Naoto Uemura, Evariste Tshibangu-Kabamba, et al. (+4)
143 [GO] 2022―Jun―29 SARS-CoV-2 Exposures of Healthcare Workers from Primary Care, Long-Term Care Facilities and Hospitals: A Nationwide Matched Case-Control Study Martin Belan, Tiffany Charmet, Laura Schaeffer, Sarah Tubiana, Xavier Duval, Jean-Christophe Lucet, et al. (+3)
144 [GO] 2022―Jun―28 Transmission of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) from pre and asymptomatic infected individuals: a systematic review update Tom Jefferson, Elizabeth A. Spencer, Igho J. Onakpoya, Annette Plu¨ddemann, John M. Conly, Carl J. Heneghan
145 [GO] 2022―Jun―21 Imaging strategies used in emergency departments for the diagnostic workup of COVID-19 patients during the first wave of the pandemic: a multicenter retrospective cost-effectiveness analysis Sabrina Kepka, Kevin Zarca, Damien Viglino, Nicolas Marjanovic, Omide Taheri, Olivier Peyrony, et al. (+13)
146 [GO] 2022―Jun―20 Re: 'early administration of tocilizumab in hospitalized COVID-19 patients with elevated inflammatory markers; COVIDSTORM' by Broman et al Timothée Klopfenstein, Vincent Gendrin, Souheil Zayet
147 [GO] 2022―Jun―20 'Characteristics Associated with Serological Covid-19 Vaccine Response and Durability in an Older Population with Significant Comorbidity' - Author’s reply Ole Schmeltz Søgaard
148 [GO] 2022―Jun―18 Refocus attention on HIV/AIDS: it was neglected during the COVID-19 pandemic Xiangyu Yan, Xuechun Wang, Lei Wang, Bo Zhang, Zhongwei Jia
149 [GO] 2022―Jun―17 Symptoms Persist in Patients Two Years after COVID-19 infection: A Prospective Follow Up Study Christopher Millet, Spandana Narvaneni, Sherif Roman, George Horani, Suhail Chaudhry, Patrick Michael, et al. (+2)
150 [GO] 2022―Jun―15 Re: 'Characteristics associated with serological Covid-19 vaccine response and durability in an older population with significant comorbidity' by Søgaard et al Maria Ester Villacorta de la Cruz, Mery Juana Vilchez Osorio, Leon Sandoval Segundo Ramos
151 [GO] 2022―May―31 N-antigenemia detection by a rapid lateral flow test predicts 90-day mortality in COVID-19: a prospective cohort study Raquel Almansa, Jose María Eiros, David de Gonzalo-Calvo, Tamara Postigo, Alicia Ortega, Raul Lopez-Izquierdo, et al. (+28)
152 [GO] 2022―May―31 Amplitudes and kinetic of antibodies after second and third doses of BNT162b2 vaccine in nonagenarians and centenarians with and without prior SARS-CoV-2 infection Edouard Tuaillon, Amandine Pisoni, Lucie Gamon, Steven Henry, Anne-Marie Mondain, Patrick Pastor, et al. (+4)
153 [GO] 2022―May―30 Hospitalisation as an outcome in ambulatory COVID-19 trials - Not applicable in every setting Isaac Núñez, Sergio Iván Valdés-Ferrer, Adrian Soto-Mota
154 [GO] 2022―May―29 Thromboprophylaxis and anticoagulation for inpatients with coronavirus disease 2019 in 2022 and beyond Michael Dalager-Pedersen
155 [GO] 2022―May―28 Severe immunosuppression is related to poorer immunogenicity to SARS-CoV-2 vaccines among people living with HIV Anaïs Corma-Gómez, Marta Fernández-Fuertes, Estefanía García, Ana Fuentes-López, Cristina Gómez-Ayerbe, Antonio Rivero-Juárez, et al. (+9)
156 [GO] 2022―May―28 Differences in environmental stability among SARS-CoV-2 variants of concern: Both Omicron BA.1 and BA.2 have higher stability Ryohei Hirose, Yoshito Itoh, Hiroshi Ikegaya, Hajime Miyazaki, Naoto Watanabe, Takuma Yoshida, et al. (+3)
157 [GO] 2022―May―27 The association between pre-exposure to glucocorticoids and other immunosuppressant drugs with severe COVID-19 outcomes Rakel Brodin, Suzanne Desirée van der Werff, Pontus Hedberg, Anna Färnert, Pontus Nauclér, Peter Bergman, Ana Requena-Méndez
158 [GO] 2022―May―25 Immunocompromized patients have been neglected in Covid-19 trials: A call for action Marius Trøseid, Maxime Hentzien, Florence Ader, Sandra Wagner Cardoso, Jose R. Arribas, Jean-Michel Molina, et al. (+9)
159 [GO] 2022―May―19 Remdesivir for the treatment of COVID-19: A systematic review and meta-analysis Todd C. Lee, Srinivas Murthy, Olivier Del Corpo, Julien Senécal, Guillaume Butler-Laporte, Zahra N. Sohani, et al. (+2)
160 [GO] 2022―May―19 Heterologous ChAdOx1 and BNT162b2 vaccination induces strong neutralizing antibody responses against SARS-CoV-2 including delta variant with tolerable reactogenicity Seongman Bae, Jae-Hoon Ko, Ju-Yeon Choi, Woo-Jung Park, So Yun Lim, Jin Young Ahn, et al. (+18)
161 [GO] 2022―May―17 Resistance mutations in SARS-CoV-2 omicron variant in patients treated with Sotrovimab Camille Vellas, Pauline Tremeaux, Arnaud Del Bello, Justine Latour, Nicolas Jeanne, Noémie Ranger, et al. (+5)
162 [GO] 2022―May―16 Re: "Predicting critical illness on initial diagnosis of COVID-19 based on easily-obtained clinical variables" by Martínez-Lacalzada et al. F. Moretto, T. Sixt, M. Blot, L. Piroth
163 [GO] 2022―May―11 Omicron (B.1.1.529) SARS-CoV-2 viral load among nasopharyngeal and oral samples compared to other Variants of Concern and impact on diagnostic testing strategy Nancy Matic, Christopher F. Lowe, Gordon Ritchie, Matthew Young, Tanya Lawson, Marc G. Romney
164 [GO] 2022―May―10 Re: 'Efficacy of Favipiravir in adults with mild COVID-19' by Bosaeed et al. Nobuaki Mori
165 [GO] 2022―May―10 Re: vertical transmission and humoral immune response following maternal infection with SARS-cov-2 by massalha et al Guangting Zeng
166 [GO] 2022―May―08 First-generation Oral Antivirals Against SARS-CoV-2 Parham Sendi, Raymund R. Razonable, Sandra B. Nelson, Alex Soriano, Rajesh Tim Gandhi
167 [GO] 2022―May―07 An open-label randomized, controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-β-1a and hydroxychloroquine in hospitalized patients with COVID-19 - Final results Florence Ader
168 [GO] 2022―May―06 Analyzing COVID-19 vaccine efficacy in vulnerable communities: efforts Beyond Addressing vaccine inequity Parham Sendi, Aaron J. Tande
169 [GO] 2022―Apr―28 BCG vaccine to reduce healthcare worker absenteeism in COVID-19 pandemic, a randomized controlled trial Thijs ten Doesschate, Thomas W. van der Vaart, Priya A. Debisarun, Esther Taks, Simone J.C.F.M. Moorlag, Nienke Paternotte, et al. (+15)
170 [GO] 2022―Apr―21 The COVID-19 vaccine health pass fraud in France David Zucman, Erwan Fourn, Alexandre Vallée
171 [GO] 2022―Apr―21 SARS-CoV-2 vaccine humoral response in adults with down syndrome Michela Sali, Angelo Carfì, Antonella Di Paola, Maria Pereyra Boza, Giuseppe Zampino, Maurizio Sanguinetti, et al. (+2)
172 [GO] 2022―Apr―15 Safety and immunogenicity of SpikoGen®, an advax-cpg55.2-adjuvanted sars-cov-2 spike protein vaccine: a phase 2 randomized placebo-controlled trial in both seropositive and seronegative populations Payam Tabarsi, Nassim Anjidani, Ramin Shahpari, Masoud Mardani, Araz Sabzvari, Babak Yazdani, et al. (+6)
173 [GO] 2022―Apr―13 Vertical transmission and humoral immune response following maternal infection with SARS-CoV-2 - A prospective multicenter cohort study Manal Massalha, Enav Yefet, Orit Rozenberg, Sofia Soltsman, Jamal Hasanein, Tatiana Smolkin, et al. (+3)
174 [GO] 2022―Apr―07 Learning from and optimising divergent pandemic responses Julian W. Tang, Kin On Kwok
175 [GO] 2022―Apr―06 ‘Vaccine effectiveness of ChAdOx1 nCoV-19 against COVID-19 in a socially vulnerable community in Rio de Janeiro, Brazil' - Author’s reply Otavio T. Ranzani, Fernando A. Bozza
176 [GO] 2022―Apr―01 COVID-19 vaccine: missed opportunities and hospital vaccine implementation Martinot Martin, Mahsa Mohseni Zadeh, Laurent Marion, Daniel Roncalez
177 [GO] 2022―Mar―31 Impact of COVID-19 and malaria Coinfection on Clinical Outcomes: A Retrospective Cohort Study Rasha Hussein, Murilo Henrique Guedes, Nada Ibraheim, Mazin M. Ali, Amal El-Tahir, Nahla Allam, et al. (+3)
178 [GO] 2022―Mar―31 In search of viable SARS-CoV-2 in the tear film: a prospective clinical study in hospitalized symptomatic patients. L. Leysen, H. Delbeke, S. Desmet, P.-P. Schauwvlieghe, P. Maes, G. Blanckaert, et al. (+3)
179 [GO] 2022―Mar―28 Evaluating the risk of drug-drug interactions with pharmacokinetic boosters: the case of ritonavir-enhanced nirmatrelvir to prevent severe COVID-19. François Girardin, Oriol Manuel, Catia Marzolini, Thierry Buclin
180 [GO] 2022―Mar―23 Mass screening strategy for the SARS-CoV-2 delta variant outbreak in Guangzhou, May 2021 Chao Zhang, Bingshao Liang, Zhile Xiong, Zhuwei Liang, Sitang Gong, Zhenwen Zhou
181 [GO] 2022―Mar―23 Inappropriate use of ivermectin during the COVID-19 pandemic: Primum non nocere! Aleksandra Barac, Michele Bartoletti, Ozlem Azap, Linda Bussini, Onder Ergonul, Robert Krause, et al. (+9)
182 [GO] 2022―Mar―23 COVID-19-associated cardiac pathology at post-mortem evaluation: A Collaborative systematic Review Raghed Almamlouk, Tarek Kashour, Sawsan Obeidat, Melanie C. Bois, Joseph J. Maleszewski, Osama A. Omrani, et al. (+46)
183 [GO] 2022―Mar―23 Questioning the justification for a fourth SARS-CoV-2 vaccine Ronit Calderon-Margalit, Jacob Strahilevitz, Ora Paltiel
184 [GO] 2022―Mar―17 Prophylactic anticoagulation with low molecular weight heparin in COVID-19: cohort studies in Denmark and Sweden Lars Christian Lund, Pontus Hedberg, Anne Helms Andreasen, Janne Petersen, Tonny Studsgaard Petersen, Anton Pottegård, et al. (+4)
185 [GO] 2022―Mar―17 Long-term evolution of humoral immune response after SARS-CoV-2 infection Elisa Teyssou, Karen Zafilaza, Sophie Sayon, Stéphane Marot, Margot Dropy, Cathia Soulie, et al. (+39)
186 [GO] 2022―Mar―16 Re: ' Vaccine Effectiveness of ChAdOx1 nCoV-19 Against COVID-19 in a Socially Vulnerable Community in Rio de Janeiro, Brazil' by Ranzani et al. Guangting Zeng
187 [GO] 2022―Mar―15 Inhaled ciclesonide for outpatient treatment of COVID-19 in adults at risk of adverse outcomes: a randomised controlled trial (COVERAGE) Alexandre Duvignaud, Edouard Lhomme, Racha Onaisi, Rémi Sitta, Ambre Gelley, Julie Chastang, et al. (+307)
188 [GO] 2022―Mar―15 Impact of SARS-CoV-2 omicron and delta sub-lineage AY.4.2 variant on neutralization by sera of patients treated with different licensed monoclonal antibodies Filippo Dragoni, Elisabetta Schiaroli, Valeria Micheli, Lia Fiaschi, Alessia Lai, Gianguglielmo Zehender, et al. (+5)
189 [GO] 2022―Mar―12 Clinical outcome in solid organ transplant recipients affected by COVID-19 compared to general population: a systematic review and meta-analysis Milo Gatti, Matteo Rinaldi, Linda Bussini, Cecilia Bonazzetti, Renato Pascale, Zeno Pasquini, et al. (+24)
190 [GO] 2022―Mar―11 Caring for older adults during the COVID-19 pandemic Virginie Prendki, Giusy Tiseo, Marco Falcone
191 [GO] 2022―Mar―11 Characteristics Associated with Serological Covid-19 Vaccine Response and Durability in an Older Population with Significant Comorbidity: The Danish Nationwide ENFORCE Study Ole Schmeltz Søgaard, Joanne Reekie, Isik Somuncu Johansen, Henrik Nielsen, Thomas Benfield, Lothar Wiese, et al. (+24)
192 [GO] 2022―Mar―11 Effectiveness of COVID-19 digital proximity tracing app in Finland Juha Rannikko, Pekka Tamminen, Roosa Hellsten, J. Pekka Nuorti, Jaana Syrjänen
193 [GO] 2022―Mar―10 Community antibiotic prescriptions during COVID-19 era: A population-based cohort study among adults Bat-Sheva Gottesman, Marcelo Low, Doron Netzer, Ronit Almog, Michal Chowers
194 [GO] 2022―Mar―10 COVID-19 in special populations Dafna Yahav
195 [GO] 2022―Mar―05 Early administration of tocilizumab in hospitalized COVID-19 patients with elevated inflammatory markers; COVIDSTORM - A prospective, randomized, single center, open label study Niklas Broman, Thijs Feuth, Tytti Vuorinen, Mika Valtonen, Ulla Hohenthal, Eliisa Löyttyniemi, et al. (+5)
196 [GO] 2022―Mar―04 Assessment of BIV1-CovIran inactivated vaccine-elicited neutralizing antibody against the emerging SARS-CoV-2 variants of concern Mohammadreza Salehi, Hamed Hosseini, Hamid Reza Jamshidi, Hasan Jalili, Payam Tabarsi, Minoo Mohraz, et al. (+6)
197 [GO] 2022―Feb―25 Length of hospital stay and risk of intensive care admission and in-hospital death among COVID-19 patients in Norway: a register-based cohort study comparing patients fully vaccinated with an mRNA vaccine to unvaccinated patients Robert Whittaker, Anja Bråthen Kristofferson, Beatriz Valcarcel Salamanca, Elina Seppälä, Karan Golestani, Reidar Kvåle, et al. (+2)
198 [GO] 2022―Feb―24 Human genetics of SARS-CoV-2 infection and critical COVID-19 Trine H. Mogensen
199 [GO] 2022―Feb―23 ESCMID COVID-19 guidelines: diagnostic testing for SARS-CoV-2 Paraskevi C. Fragkou, Giulia De Angelis, Giulia Menchinelli, Fusun Can, Federico Garcia, Florence Morfin-Sherpa, et al. (+6)
200 [GO] 2022―Feb―21 Different performance of three point-of-care SARS-CoV-2 antigen detection devices in symptomatic patients and close asymptomatic contacts: a real-life study Pilar Escribano, Ana-Erika Sánchez-Pulido, José González-Leiva, Iván Valero-López, Pilar Catalán, Patricia Muñoz, et al. (+64)
201 [GO] 2022―Feb―19 Vaccines alone will not prevent COVID-19 outbreaks among migrant workers - The example of meat processing plants Gabriel E. Fabreau, Linda Holdbrook, Cheryl E. Peters, Paul E. Ronksley, Amir Attaran, Kerry McBrien, Kevin Pottie
202 [GO] 2022―Feb―18 An Overview of COVID-19 in solid organ transplantation Luther Bartelt, David van Duin
203 [GO] 2022―Feb―17 Effective bubble-based testing for SARS-CoV-2 using swab-pooling Yuval Cohen, Nadav Bamberger, Orna Mor, Ronen Walfisch, Shay Fleishon, Itay Varkovitzky, et al. (+8)
204 [GO] 2022―Feb―17 Re: ‘predictors and microbiology of respiratory and bloodstream infection in patients with COVID-19’ by Langford et al Johan Van Laethem, Sabine D. Allard
205 [GO] 2022―Feb―17 Reconstruction of a large-scale outbreak of SARS-CoV-2 infection in Iceland informs vaccination strategies Kristjan E. Hjorleifsson, Solvi Rognvaldsson, Hakon Jonsson, Arna B. Agustsdottir, Margret Andresdottir, Kolbrun Birgisdottir, et al. (+37)
206 [GO] 2022―Feb―17 ESCMID rapid guidelines for assessment and management of long COVID Dana Yelin, Charalampos D. Moschopoulos, Ili Margalit, Effrossyni Gkrania-Klotsas, Francesco Landi, Jean-Paul Stahl, Dafna Yahav
207 [GO] 2022―Feb―16 High SARS-CoV-2 Seroprevalence among Healthcare Workers in Bamako Referral Hospitals: A Prospective Multi-Site Cross-sectional Study (ANRS COV11) Almoustapha Issiaka Maiga, Mahamadou Saliou, Amadou kodio, Abdoulaye Mamadou Traore, Garan Dabo, Philippe Flandre, et al. (+6)
208 [GO] 2022―Feb―16 Reactogenicity among healthcare workers following a BNT162b2 or mRNA-1273 second dose after priming with a ChAdOx1 nCOV-19 vaccine Aurelie Baldolli, Anna Fournier, Renaud Verdon, Jocelyn Michon
209 [GO] 2022―Feb―15 Clinical characteristics of SARS-CoV-2 fully-vaccinated patients dying with COVID-19 in Italy Luigi Palmieri, Marco Floridia, Marina Giuliano, Dorina Tiple, Cinzia Lo Noce, Paola Meli, et al. (+66)
210 [GO] 2022―Feb―10 Lower probability of persistence of total anti-SARS-CoV-2 antibodies after COVID-19 among people living with HIV Juan Macías, Marta Fernández-Fuertes, Noemí Oliver, Anaïs Corma-Gómez, Luis M. Real, Juan A. Pineda
211 [GO] 2022―Feb―10 Defining COVID-19 associated pulmonary aspergillosis: systematic review and meta-analysis Ruwandi M. Kariyawasam, Tanis C. Dingle, Brittany E. Kula, Ben Vandermeer, Wendy I. Sligl, Ilan S. Schwartz
212 [GO] 2022―Feb―10 External validation of the PRIORITY model in predicting COVID-19 critical illness in vaccinated and unvaccinated patients Sean Wei Xiang Ong, Sai Meng Tham, Lin Pin Koh, Christopher Dugan, Bo Yan Khoo, Dongdong Ren, et al. (+4)
213 [GO] 2022―Feb―10 Evidence based dosing of convalescent plasma for COVID-19 in future trials Bart JA. Rijnders, Sammy Huygens, Oriol Mitjà
214 [GO] 2022―Feb―10 Low placental weight and altered metabolic scaling after severe acute respiratory syndrome coronavirus type 2 infection during pregnancy: a prospective multicentric study Anda-Petronela Radan, David Baud, Guillaume Favre, Andrea Papadia, Daniel Surbek, Marc Baumann, Luigi Raio
215 [GO] 2022―Feb―10 'Predicting critical illness on initial diagnosis of COVID-19 based on easily-obtained clinical variables' - Author’s reply Adrian Viteri-Nöel, Miguel Martínez-Lacalzada, Martin Fabregate, Luis Manzano
216 [GO] 2022―Feb―09 Vaccine effectiveness of ChAdOx1 nCoV-19 against COVID-19 in a socially vulnerable community in Rio de Janeiro, Brazil: a test-negative design study Otavio T. Ranzani, Amanda A.B. Silva, Igor T. Peres, Bianca B.P. Antunes, Thiago W. Gonzaga-da-Silva, Daniel R. Soranz, et al. (+3)
217 [GO] 2022―Feb―04 'Predictors and microbiology of respiratory and bloodstream bacterial infection in patients with COVID-19' - Author’s reply Bradley J. Langford, Miranda So, Valerie Leung, Sumit Raybardhan, Jennifer Lo, Tiffany Kan, et al. (+4)
218 [GO] 2022―Feb―03 Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods: A systematic review and meta-analysis Mohamad Salim Alkodaymi, Osama Ali Omrani, Nader A. Fawzy, Bader Abou Shaar, Raghed Almamlouk, Muhammad Riaz, et al. (+9)
219 [GO] 2022―Feb―03 Safe university: A guide for open academic institutions through the pandemic Manolis Wallace, Georgios Pappas
220 [GO] 2022―Feb―03 ESCMID guidelines on testing for SARS-CoV-2 in asymptomatic individuals to prevent transmission in the healthcare setting Elena Carrara, David S.Y. Ong, Khetam Hussein, Siran Keske, Anders F. Johansson, Elisabeth Presterl, et al. (+3)
221 [GO] 2022―Jan―25 Accelerating clinical trial implementation in the context of the COVID-19 pandemic Andrzej Jan Rys, Irene Norstedt
222 [GO] 2022―Jan―25 Corrigendum to “Seroprevalence of SARS-CoV-2 in 1922 blood donors from the Lodi Red Zone and adjacent Lodi metropolitan and suburban area”, Clin Microbiol Infect 2021 Jun;27(6):914.e1-914.e4 Irene Cassaniti, Elena Percivalle, Antonella Sarasini, Giuseppe Cambiè, Edoardo Vecchio Nepita, Roberta Maserati, et al. (+7)
223 [GO] 2022―Jan―20 Prospective evaluation of the point-of-care use of a rapid antigenic SARS-CoV-2 immunochromatographic test in a pediatric emergency department Ollier Quentin, Pillet Sylvie, Mory Olivier, Gagnaire Julie, Thuiller Charlotte, Annino Nadine, et al. (+5)
224 [GO] 2022―Jan―12 Re: ‘Accelerating clinical trial implementation in the context of the COVID-19 pandemic' by Diallo et al Marius Trøseid, Alpha Diallo, Maya Hites, John-Arne Røttingen, Yazdan Yazdanpanah
225 [GO] 2022―Jan―11 Efficacy of favipiravir in adults with mild COVID-19: a randomized, double-blind, multicenter, placebo-controlled trial clinical trial Mohammad Bosaeed, Ahmad Alharbi, Ebrahim Mahmoud, Sanaa Alrehily, Mohannad Bahlaq, Zied Gaifer, et al. (+25)
226 [GO] 2022―Jan―10 ‘ESCMID COVID-19 living guidelines: drug treatment and clinical management’- Author’s reply Michele Bartoletti
227 [GO] 2022―Jan―10 Has the COVID-19 pandemic wiped out the seasonality of outpatient antibiotic use and influenza activity? A time-series analysis from 2014 to 2021 Ana Belén Guisado-Gil, Regina Sandra Benavente, Román Villegas-Portero, María Victoria Gil-Navarro, Raquel Valencia, Germán Peñalva, José Miguel Cisneros
228 [GO] 2022―Jan―06 Assessment of the reporting quality of randomised controlled trials related to the pharmacotherapy of COVID-19 based on the CONSORT 2010 checklist: A Systematic Review Youn-Joo Jung, Yunkyoung Oh, Purja Sujata, Hyokeun Jeong, Eunyoung Kim
229 [GO] 2022―Jan―06 Remdesivir associated bradycardia might be a sign of good prognosis in COVID-19 patients Marko Lucijanic, Petra Bistrovic
230 [GO] 2022―Jan―06 Rapid evaluation of the safety of Covid-19 vaccines: how well have we done? Elizabeth Miller
231 [GO] 2021―Dec―24 Outbreak of SARS-CoV-2 B.1.617.2 (Delta) variant in a nursing home 28 weeks after two doses of mRNA anti-Covid-19 vaccines: evidence of a waning immunity Alice Pierobon, Alessandra Dal Zotto, Antonio Antico, De Antoni Mario Ernesto, Liviano Vianello, Monica Gennari, et al. (+4)
232 [GO] 2021―Dec―23 Persistence of the neutralising antibody response after SARS-CoV-2 infection Sang-Mu Shim, Jun-Won Kim, Sunhee Jung, Yujung Jung, Hye-Min Woo, Jeong-Sun Yang, et al. (+2)
233 [GO] 2021―Dec―16 Zoonotic spillover of SARS-CoV-2: mink-adapted virus in humans Lukasz Rabalski, Maciej Kosinski, Natalia Mazur-Panasiuk, Boguslaw Szewczyk, Krystyna Bienkowska-Szewczyk, Ravi Kant, et al. (+3)
234 [GO] 2021―Dec―16 Real-world safety data for the Pfizer BNT162b2 SARS-CoV-2 vaccine, historical cohort study - Author’s reply David Shasha, Anthony D. Heymann, Galia Zacay
235 [GO] 2021―Dec―13 SARS-CoV-2 vector and m-RNA based vaccines with respect to postvaccination infections among staff of a tertiary care hospital Sophie Brunner-Ziegler, Tibor Spath, Gabriela Kornek, Franz König, Bernhard Parschalk, Maximilian Schnetzinger, et al. (+5)
236 [GO] 2021―Dec―11 Re: ‘ESCMID COVID-19 living guidelines: drug treatment and clinical management’ by Bartoletti et al Nicolas Dauby
237 [GO] 2021―Dec―11 The role of observational studies based on secondary data in studying SARS-CoV-2 vaccines Noam Barda, Noa Dagan
238 [GO] 2021―Dec―01 Coronavirus (SARS-CoV-2) causes lung inflammation and injury Le-Le Wang, Jia-Wei Yang, Jin-Fu Xu
239 [GO] 2021―Nov―26 Predictors and microbiology of respiratory and bloodstream bacterial infection in patients with COVID-19: living rapid review update and meta-regression Bradley J. Langford, Miranda So, Valerie Leung, Sumit Raybardhan, Jennifer Lo, Tiffany Kan, et al. (+5)
240 [GO] 2021―Nov―25 Nationwide effectiveness of five SARS-CoV-2 vaccines in Hungary - The HUN-VE study Zoltán Vokó, Zoltán Kiss, György Surján, Orsolya Surján, Zsófia Barcza, Bernadett Pályi, et al. (+9)
241 [GO] 2021―Nov―25 A selected view does not represent the real world of SARS-CoV-2 vaccination outcomes Fulvio Alexandre Scorza, Josef Finsterer
242 [GO] 2021―Nov―24 Post-acute COVID-19 syndrome (PACS): a new tsunami requiring a universal case definition Gema M. Lledó, Jacobo Sellares, Carlos Brotons, Mireia Sans, Juana M. Díez Antón, Julià Blanco, et al. (+4)
243 [GO] 2021―Nov―24 Evaluation of Financial Conflicts of Interest and Drug Statements in the Coronavirus Disease 2019 Clinical Practice Guideline in Japan Takanao Hashimoto, Anju Murayama, Hanano Mamada, Hiroaki Saito, Tetsuya Tanimoto, Akihiko Ozaki
244 [GO] 2021―Nov―23 Outcomes assessed in therapeutic randomised controlled trials in hospitalised patients with COVID-19: is the meta Core outcome set (meta-COS) adopted? Markus Fally, Alexander G. Mathioudakis, James Wingfield Digby, Paula R. Williamson
245 [GO] 2021―Nov―23 Virological and serological kinetics of SARS-CoV-2 Delta variant vaccine-breakthrough infections: a multi-center cohort study Po Ying Chia, Sean Wei Xiang Ong, Calvin J. Chiew, Li Wei Ang, Jean-Marc Chavatte, Tze-Minn Mak, et al. (+13)
246 [GO] 2021―Nov―22 ESCMID COVID-19 Living guidelines: drug treatment and clinical management Michele Bartoletti, Ozlem Azap, Aleksandra Barac, Linda Bussini, Onder Ergonul, Robert Krause, et al. (+8)
247 [GO] 2021―Nov―17 Immunological and clinical efficacy of COVID-19 vaccines in immunocompromised populations: a systematic review Simon Galmiche, Liem Binh Luong Nguyen, Eric Tartour, Xavier de Lamballerie, Linda Wittkop, Paul Loubet, Odile Launay
248 [GO] 2021―Nov―10 Public opinion on a mandatory COVID-19 vaccination policy in France: a cross sectional survey Amandine Gagneux-Brunon, Elisabeth Botelho-Nevers, Marion Bonneton, Patrick Peretti-Watel, Pierre Verger, Odile Launay, Jeremy K. Ward
249 [GO] 2021―Nov―10 Persistent SARS-CoV-2 infection with repeated clinical recurrence in a patient with common variable immunodeficiency Marta Dafne Cabañero-Navalon, Victor Garcia-Bustos, Paula Ruiz-Rodriguez, Iñaki Comas, Mireia Coscollá, Llúcia Martinez-Priego, et al. (+2)
250 [GO] 2021―Nov―09 Rectally shed SARS-CoV-2 in COVID-19 inpatients is consistently lower than respiratory shedding and lacks infectivity Rune Micha Pedersen, Ditte Sandfeld Tornby, Line Lundegård Bang, Lone Wulff Madsen, Marianne Nielsine Skov, Thomas Vognbjerg Sydenham, et al. (+4)
251 [GO] 2021―Nov―08 Accelerating clinical trial implementation in the context of the COVID-19 pandemic: challenges, lessons learned and recommendations from DisCoVeRy and the EU-SolidAct EU response group Alpha Diallo, Marius Trøseid, Victoria Charlotte Simensen, Anaïs Boston, Jacques DEMOTES, Inge Christoffer Olsen, et al. (+22)
252 [GO] 2021―Nov―03 Timing of SARS-CoV-2 vaccination during the third trimester of pregnancy and transplacental antibody transfer: a prospective cohort study Amihai Rottenstreich, Gila Zarbiv, Esther Oiknine-Djian, Olesya Vorontsov, Roy Zigron, Geffen Kleinstern, et al. (+2)
253 [GO] 2021―Oct―30 The impact of COVID-19 on community antibiotic use in Canada: an ecological study Braden D. Knight, Jayson Shurgold, Glenys Smith, Derek R. MacFadden, Kevin L. Schwartz, Nick Daneman, et al. (+2)
254 [GO] 2021―Oct―29 Transmission of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) from pre and asymptomatic infected individuals. A systematic review Tom Jefferson, Elizabeth A. Spencer, Jon Brassey, Igho J. Onakpoya, Elena C. Rosca, Annette Plüddemann, et al. (+3)
255 [GO] 2021―Oct―29 SARS-CoV-2 infection despite high levels of vaccine-induced anti-RBD antibodies: a study on 1110 healthcare professionals from a northern Italian university hospital Davide Ferrari, Nicola Clementi, Nicasio Mancini, Massimo Locatelli
256 [GO] 2021―Oct―27 Dynamic SARS-CoV-2 specific B cell and T cell responses following immunization of an inactivated COVID-19 vaccine Yuxin Chen, Shengxia Yin, Xin Tong, Yue Tao, Jun Ni, Jie Pan, et al. (+9)
257 [GO] 2021―Oct―27 Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: A narrative review Thibault Fiolet, Yousra Kherabi, Conor-James MacDonald, Jade Ghosn, Nathan Peiffer-Smadja
258 [GO] 2021―Oct―09 A new SARS-CoV-2 variant poorly detected by RT-PCR on nasopharyngeal samples, with high lethality: an observational study Pierre Fillâtre, Marie-José Dufour, Sylvie Behillil, Remi Vatan, Pascale Reusse, Alice Gabellec, et al. (+22)
259 [GO] 2021―Oct―05 Likelihood of COVID-19 vaccination among primary school students in Hong Kong Kin On Kwok, Kin-Kit Li, Wan In Wei, Margaret Ting Fong Tsoi, Arthur Tang, Hugh Simon Lam, et al. (+2)
260 [GO] 2021―Oct―05 Chilblains during lockdown are associated with household exposure to SARS-CoV-2. A multicentre case-control study Florence Poizeau, Emmanuel Oger, Sébastien Barbarot, Yannick Le Corre, Mahtab Samimi, Emilie Brenaut, et al. (+12)
261 [GO] 2021―Oct―05 Immunological response against SARS-CoV-2 following full-dose administration of Comirnaty® COVID-19 vaccine in nursing home residents Eliseo Albert, Javier S. Burgos, Salvador Peiró, Dolores Salas, Hermelinda Vanaclocha, Estela Giménez, et al. (+21)
262 [GO] 2021―Oct―02 Corrigendum to ‘Detection of SARS-CoV-2 N-antigen in blood during acute COVID-19 provides a sensitive new marker and new testing alternatives’ [Clinical Microbiology and Infection 27/5 (2021) 789-790] Quentin Le Hingrat, Benoit Visseaux, Cédric Laouenan, Sarah Tubiana, Lila Bouadma, Yazdan Yazdanpanah, et al. (+12)
263 [GO] 2021―Sep―30 Association between first language and SARS-CoV-2 infection rates, hospitalization, intensive care admissions and death in Finland: a population-based observational cohort study Ville Holmberg, Heli Salmi, Salla Kattainen, Jukka Ollgren, Anu Kantele, Juulia Pynnönen, et al. (+6)
264 [GO] 2021―Sep―30 Predictors of poor prognosis in healthy, young, individuals with SARS-CoV-2 infections Carolina Espejo-Paeres, Ramón Arroyo Espliguero, Aitor Uribarri, Berta Antón-Huguet, Rodolfo Romero, Inmaculada Fernández-Rozas, et al. (+17)
265 [GO] 2021―Sep―28 Real-world safety data for the Pfizer BNT162b2 SARS-CoV-2 vaccine, historical cohort study David Shasha, Ronen Bareket, Fabienne Hershkowitz Sikron, Omer Gertel, Judith Tsamir, David Dvir, et al. (+3)
266 [GO] 2021―Sep―27 Humoral and cell-mediated response elicited by SARS-CoV-2 mRNA vaccine BNT162b2 e in healthcare workers: a longitudinal observational study Irene Cassaniti, Federica Bergami, Elena Percivalle, Elisa Gabanti, Josè Camilla Sammartino, Alessandro Ferrari, et al. (+14)
267 [GO] 2021―Sep―27 Update on SARS-CoV-2 seroprevalence - Regional and worldwide Ali Rostami, Mahdi Sepidarkish, Aylar Fazlzadeh, Ali H. Mokdad, Aida Sattarnezhad, Sahar Esfandyari, et al. (+8)
268 [GO] 2021―Sep―27 Aortic [18F] FDG-PET/CT hypermetabolism in patients with long COVID: a retrospective study Pierre Dudouet, Serge Cammilleri, Eric Guedj, Alexis Jacquier, Didier Raoult, Carole Eldin
269 [GO] 2021―Sep―17 Seroprevalence of SARS-CoV-2 antibodies and reduced risk of reinfection through six months: a Danish observational cohort study of 44,000 healthcare workers Kasper Iversen, Jonas Henrik Kristensen, Rasmus Bo Hasselbalch, Mia Pries-Heje, Pernille Brok Nielsen, Andreas Dehlbæk Knudsen, et al. (+24)
270 [GO] 2021―Sep―16 Obesity, diabetes, hypertension and severe outcomes among inpatients with COVID-19: a nationwide study Laurent Bailly, Roxane Fabre, Johan Courjon, Michel Carles, Jean Dellamonica, Christian Pradier
271 [GO] 2021―Sep―16 Monitoring the SARS-CoV-2 pandemic: screening algorithm with SNP detection for the rapid identification of established and emerging variants Joachim Mertens, Jasmine Coppens, Katherine Loens, Marie Le Mercier, Basil Britto Xavier, Christine Lammens, et al. (+4)
272 [GO] 2021―Sep―16 Influence of treatment with neutralizing monoclonal antibodies on the SARS-CoV-2 nasopharyngeal load and quasispecies Camille Vellas, Arnaud Del Bello, Alexa Debard, Zara Steinmeyer, Laure Tribaudeau, Noémie Ranger, et al. (+5)
273 [GO] 2021―Sep―08 Outcomes and proportions of pregnant females during the first and consecutively waves of COVID-19: observational cohort study Cathrin Kodde, Marzia Bonsignore, Sven Hohenstein, Ralf Kuhlen, Andreas Meier-Hellmann, Andreas Bollmann, Irit Nachtigall
274 [GO] 2021―Sep―08 Intended category: Invited editorial repurposed drugs for COVID-19: threshold and proof requirements for trials Mical Paul, Andre C. Kalil
275 [GO] 2021―Sep―03 Time to resolution of respiratory and systemic COVID-19 symptoms in community setting Aurélien Dinh, Luc Jaulmes, Agnès Dechartres, Clara Duran, Hélène Mascitti, Xavier Lescure, et al. (+46)
276 [GO] 2021―Aug―29 Intradermal immunisation - A dose-sparing strategy to combat global shortages of SARS-CoV-2 vaccines? Jenny L. Schnyder, Hanna K. de Jong, Martin P. Grobusch
277 [GO] 2021―Aug―26 Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients- a multinational observational study by the European Confederation of Medical Mycology Juergen Prattes, Joost Wauters, Daniele Roberto Giacobbe, Jon Salmanton-García, Johan Maertens, Marc Bourgeois, et al. (+43)
278 [GO] 2021―Aug―24 Immunogenicity and safety of the BNT162b2 mRNA Covid-19 vaccine in people living with HIV-1 Itzchak Levy, Anat Wieder - Finesod, Vladyslav Litchevsky, Asaf Biber, Victoria Indenbaum, Liraz Olmer, et al. (+8)
279 [GO] 2021―Aug―23 Tocilizumab for COVID-19 in pregnancy and lactation: a narrative review Sarah CJ. Jorgensen, Stephen E. Lapinsky
280 [GO] 2021―Aug―21 Which are the best COVID-19 vaccines? Ali S. Omrani, Imad M. Tleyjeh
281 [GO] 2021―Aug―19 Rate and severity of suspected SARS-Cov-2 reinfection in a cohort of PCR-positive COVID-19 patients Jeff Slezak, Katia Bruxvoort, Heidi Fischer, Benjamin Broder, Bradley Ackerson, Sara Tartof
282 [GO] 2021―Aug―13 Diagnostic usefulness of subgenomic RNA detection of viable SARS-CoV-2 in patients with COVID-19 Ji Yeun Kim, Joon-Yong Bae, Seongman Bae, Hye Hee Cha, Ji-Soo Kwon, Mi Hyun Suh, et al. (+8)
283 [GO] 2021―Aug―13 Combined epidemiological and genomic analysis of nosocomial SARS-CoV-2 infection early in the pandemic and the role of unidentified cases in transmission Luke B. Snell, Chloe L. Fisher, Usman Taj, Oliver Stirrup, Blair Merrick, Adela Alcolea-Medina, et al. (+17)
284 [GO] 2021―Aug―12 Precautions after vaccinating immunosuppressed patients with mRNA-based vaccines against SARS-CoV-2 - does one size fit all? Noam Tau, Oriol Manuel, Benaya Rozen-Zvi, Liat Shargian, Dafna Yahav
285 [GO] 2021―Aug―12 Mucosal immunity to SARS-CoV-2: a clinically relevant key to deciphering natural and vaccine-induced defences Claude Matuchansky
286 [GO] 2021―Aug―09 COVID-19 vaccination in Israel Khitam Muhsen, Dani Cohen
287 [GO] 2021―Aug―09 Upper respiratory tract SARS-CoV-2 RNA loads in symptomatic and asymptomatic children and adults Rosa Costa, Felipe Bueno, Eliseo Albert, Ignacio Torres, Silvia Carbonell-Sahuquillo, Ana Barrés-Fernández, et al. (+7)
288 [GO] 2021―Aug―08 COVID-19 associated mucormycosis: a life-threatening complication in patients admitted with severe to critical COVID-19 from Pakistan Nosheen Nasir, Joveria Farooqi, Faisal Mahmood, Kauser Jabeen
289 [GO] 2021―Aug―08 COVID-19 infodemics: the role of mainstream and social media Daniele Focosi, David Navarro, Fabrizio Maggi, Emmanuel Roilides, Guido Antonelli
290 [GO] 2021―Aug―08 Antibody responses to BNT162b2 mRNA COVID-19 vaccine and their predictors among healthcare workers in a tertiary referral hospital in Japan Takahiro Kageyama, Kei Ikeda, Shigeru Tanaka, Toshibumi Taniguchi, Hidetoshi Igari, Yoshihiro Onouchi, et al. (+10)
291 [GO] 2021―Aug―08 Current COVID-19 vaccine trials in high-income countries: are placebo-controlled trials ethical? Rafael Dal-Ré, Arthur L. Caplan
292 [GO] 2021―Aug―08 Both SARS-CoV-2 infection and vaccination in pregnancy elicited neutralizing antibodies in pregnant women and newborns Irene Cassaniti, Elena Percivalle, Paola Zelini, Kimta Ngaradoumbe Nanhorngue, Anna Parolo, Valeria Bernardi, et al. (+6)
293 [GO] 2021―Aug―04 Self-testing for the detection of SARS-CoV-2 infection with rapid antigen tests for people with suspected COVID-19 in the community J.J.J.M. Stohr, V.F. Zwart, G. Goderski, A. Meijer, C.R.S. Nagel-Imming, M.F.Q. Kluytmans-van den Bergh, et al. (+9)
294 [GO] 2021―Jul―28 Antibody response induced by the BNT162b2 mRNA COVID-19 vaccine in a cohort of health-care workers, with or without prior SARS-CoV-2 infection: a prospective study Dora Buonfrate, Chiara Piubelli, Federico Gobbi, Davide Martini, Giulia Bertoli, Tamara Ursini, et al. (+13)
295 [GO] 2021―Jul―26 Intravenous immunoglobulins for the treatment of the hyper-inflammatory response in COVID-19. Another failure of immunomodulatory therapy? Francisco López-Medrano, José María Aguado
296 [GO] 2021―Jul―26 The potential of SARS-CoV-2 antigen-detection tests in the screening of asymptomatic persons Jonas Wachinger, Ioana Diana Olaru, Susanne Horner, Paul Schnitzler, Klaus Heeg, Claudia M. Denkinger
297 [GO] 2021―Jul―16 Duration of SARS-CoV-2 viral culture Positivity among different specimen types N. Kojima, C. Mores, N. Farsai, J.D. Klausner
298 [GO] 2021―Jul―15 Predicting critical illness on initial diagnosis of COVID-19 based on easily-obtained clinical variables: development and validation of the PRIORITY model Miguel Martinez-Lacalzada, Adrián Viteri-Noël, Luis Manzano, Martin Fabregate, Manuel Rubio-Rivas, Sara Luis Garcia, et al. (+36)
299 [GO] 2021―Jul―13 Effectiveness of mRNA-BNT162b2, mRNA-1273, and ChAdOx1 nCoV-19 vaccines against COVID-19 in health care workers: an observational study using surveillance data Christophe Paris, Sophie Perrin, Stephanie Hamonic, Baptiste Bourget, Clémence Roué, Olivier Brassard, et al. (+6)
300 [GO] 2021―Jul―11 Viral populations of SARS-CoV-2 in upper respiratory tract, placenta, amniotic fluid and umbilical cord blood support viral replication in placenta Maria Piñana, Josep F. Abril, Cristina Andrés, Aroa Silgado, Alexandra Navarro, Anna Suy, et al. (+4)
301 [GO] 2021―Jul―10 The potential clinical utility of measuring SARS-CoV-2-specific T-cell responses Delia Goletti, Linda Petrone, Davide Manissero, Antonio Bertoletti, Sonia Rao, Nduku Ndunda, et al. (+2)
302 [GO] 2021―Jul―07 Outbreak of SARS-CoV-2 infection in a long-term care facility after COVID-19 BNT162b2 mRNA vaccination Martin Martinot, Stéphane Carnein, Christian Kempf, Pierre Gantner, Floriane Gallais, Samira Fafi-Kremer
303 [GO] 2021―Jul―07 BNT162b2 vaccine breakthrough: clinical characteristics of 152 fully-vaccinated hospitalized COVID-19 patients in Israel Tal Brosh-Nissimov, Efrat Orenbuch-Harroch, Michal Chowers, Meital Elbaz, Lior Nesher, Michal Stein, et al. (+10)
304 [GO] 2021―Jul―07 Immunomodulatory therapy, risk factors and outcomes of hospital-acquired bloodstream infection in patients with severe COVID-19 pneumonia: a Spanish case-control matched multicenter study (BACTCOVID) Gabriela Abelenda-Alonso, Alexander Rombauts, Carlota Gudiol, Isabel Oriol, Antonella Simonetti, Ana Coloma, et al. (+15)
305 [GO] 2021―Jun―29 SARS-CoV-2 new infections among health care workers after the first dose of the BNT162b2 mRNA Covid-19 vaccine. a hospital wide cohort study Carlos Guijarro, Isabel Galán, Diana Martínez-Ponce, Elia Pérez-Fernández, Maria José Goyanes, Virgilio Castilla, María Velasco
306 [GO] 2021―Jun―28 Risk of coronavirus disease 2019 transmission in an emergency department with multiple open beds Hyemin Chung, Mi-Na Kim, Won Young Kim, Man-Seong Park, Jiwon Jung, Sung-Han Kim
307 [GO] 2021―Jun―28 Does SARS-CoV-2 re-infection depends on virus variant? Philippe Gautret, Linda Houhamdi, Nhu Ngog Nguyen, Van Thuan Hoang, Audrey Giraud-Gatineau, Didier Raoult
308 [GO] 2021―Jun―27 COVID-19 associated pulmonary aspergillosis (CAPA): how big a problem is it? Arnaud Fekkar, Dionysios Neofytos, M. Hong Nguyen, Cornelius J. Clancy, Dimitrios P. Kontoyiannis, Frederic Lamoth
309 [GO] 2021―Jun―27 Improved immunogenicity against SARS-CoV-2 in a solid organ transplant recipient by switching vaccines Valentin al Jalali, Sabine Scherzer, Markus Zeitlinger
310 [GO] 2021―Jun―26 Prevalence and factors associated with SARS-CoV-2 seropositivity in the Spanish HIV Research Network Cohort Juan Berenguer, Cristina Díez, María Martín-Vicente, Rafael Mican, María J. Pérez-Elías, Lucio J. García-Fraile, et al. (+18)
311 [GO] 2021―Jun―24 B and T cell immune responses elicited by the Comirnaty® COVID-19 vaccine in nursing home residents Ignacio Torres, Eliseo Albert, Estela Giménez, María Jesús Alcaraz, Pilar Botija, Paula Amat, et al. (+6)
312 [GO] 2021―Jun―23 Cardiac sequelae after COVID-19 recovery: a systematic review Mohammad Said Ramadan, Lorenzo Bertolino, Rosa Zampino, Emanuele Durante-Mangoni, Emanuele Durante-Mangoni, Domenico Iossa, et al. (+17)
313 [GO] 2021―Jun―19 Covid-19 vaccination in solid-organ transplant recipients: generating new data as fast as possible, but taking clinical decisions as slow as necessary Oriol Manuel
314 [GO] 2021―Jun―19 Congenital infection of SARS-CoV-2 in live-born neonates: a population-based descriptive study Itziar Garcia-Ruiz, Elena Sulleiro, Berta Serrano, Irene Fernandez-Buhigas, Leire Rodriguez-Gomez, David Sanchez-Nieves, et al. (+19)
315 [GO] 2021―Jun―15 Impact of dexamethasone on SARS-CoV-2 concentration kinetics and antibody response in hospitalised COVID-19 patients - results from a prospective observational study Barbara Mühlemann, Charlotte Thibeault, David Hillus, Elisa T. Helbig, Lena J. Lippert, Pinkus Tober-Lau, et al. (+93)
316 [GO] 2021―Jun―12 Reconstituted mRNA Covid-19 vaccines may maintain stability after continuous movement Santiago Grau, Olivia Ferrández, Elena Martín-García, Rafael Maldonado
317 [GO] 2021―Jun―09 The seroprevalence of SARS-CoV-2 antibodies among health care workers before the Era of vaccination: A systematic review and meta-analysis İlker Kayı, Bahar Madran, Şiran Keske, Özge Karanfil, Jose Ramon Arribas, Natalia Psheniсhnaya, et al. (+3)
318 [GO] 2021―Jun―08 National surveillance of bacterial and fungal co- and secondary infection in COVID-19 patients in England - Lessons from the first wave Sarah M. Gerver, Rebecca Guy, Kate Wilson, Simon Thelwall, Olisaeloka Nsonwu, Graeme Rooney, et al. (+4)
319 [GO] 2021―Jun―07 The interface between COVID-19 and bacterial healthcare-associated infections Ronan F. O’Toole
320 [GO] 2021―Jun―07 Prevalence of COVID-19 in Iran: results of the first survey of the Iranian COVID-19 Serological Surveillance program Kazem Khalagi, Safoora Gharibzadeh, Davood Khalili, Mohammad Ali Mansournia, Siamak Mirab Samiee, Saeide Aghamohamadi, et al. (+11)
321 [GO] 2021―Jun―07 Impact of the COVID-19 pandemic on the homeless: results from a retrospective closed cohort in France (March-May 2020) Maya HUSAIN, Anne RACHLINE, Anthony COUSIEN, Simon ROLLAND, Claire ROUZAUD, Valentine Marie FERRE, et al. (+7)
322 [GO] 2021―Jun―07 Socioeconomic disparities and COVID-19 vaccination acceptance: a nationwide ecologic study Gil Caspi, Avshalom Dayan, Yael Eshal, Sigal Liverant-Taub, Gilad Twig, Uri Shalit, et al. (+3)
323 [GO] 2021―Jun―07 Quantitative SARS-CoV-2 anti-spike responses to Pfizer-BioNTech and Oxford-AstraZeneca vaccines by previous infection status David W. Eyre, Sheila F. Lumley, Jia Wei, Stuart Cox, Tim James, Anita Justice, et al. (+17)
324 [GO] 2021―Jun―07 Negative SARS-cov-2 antibodies, T-cell response and virus neutralisation following full vaccination in a renal transplant recipient - A call for vigilance Rune M. Petersen, Ditte S. Tornby, Claus Bistrup, Isik S. Johansen, Thomas E. Andersen, Ulrik S. Justesen
325 [GO] 2021―Jun―06 Saliva testing for SARS-CoV-2 in children Vanessa Clifford, Nigel Curtis
326 [GO] 2021―May―26 An open-label randomized, controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-β-1a and hydroxychloroquine in hospitalized patients with COVID-19 Florence Ader, Nathan Peiffer-Smadja, Julien Poissy, Maude Bouscambert-Duchamp, Drifa Belhadi, Alpha Diallo, et al. (+52)
327 [GO] 2021―May―24 Clinical outcomes in COVID-19 patients infected with different SARS-cov-2 variants in marseille, France Thi Loi Dao, Van Thuan Hoang, Nhu Ngoc Nguyen, Jérémy Delerce, Hervé Chaudet, Anthony Levasseur, et al. (+4)
328 [GO] 2021―May―24 Use of an antiviral mouthwash as a barrier measure in the sars-cov-2 transmission in adults with asymptomatic to mild COVID-19: a multicenter, randomized, double-blind controlled trial Florence Carrouel, Martine Valette, Emilie Gadea, Aurélie Esparcieux, Gabriela Illes, Marie Elodie Langlois, et al. (+6)
329 [GO] 2021―May―24 SARS-CoV-2 N gene dropout and N gene Ct value shift as indicator for the presence of B.1.1.7 lineage in a commercial multiplex PCR assay Wollschlaeger P, Todt D, Gerlitz N, Pfaender S, Bollinger T, Sing A, et al. (+7)
330 [GO] 2021―May―19 Non-occupational and occupational factors associated with specific SARS-CoV-2 antibodies among hospital workers - A multicentre cross-sectional study Christian R. Kahlert, Raphael Persi, Sabine Güsewell, Thomas Egger, Onicio B. Leal-Neto, Johannes Sumer, et al. (+19)
331 [GO] 2021―May―19 Intravenous immunoglobulin treatment for patients with severe COVID-19: a retrospective multi-center study Jiao Liu, Yizhu Chen, Ranran Li, Zhixiong Wu, Qianghong Xu, Zhongyi Li, et al. (+14)
332 [GO] 2021―May―17 Drug reaction with eosinophilia and systemic symptoms (DRESS) in patients with COVID-19 Giuseppe A. Ramirez, Emanuel Della-Torre, Moreno Tresoldi, Paolo Scarpellini, Fabio Ciceri, Lorenzo Dagna, Mona-Rita Yacoub
333 [GO] 2021―May―17 Novel SARS-CoV-2 variants: the pandemics within the pandemic Erik Boehm, Ilona Kronig, Richard A. Neher, Isabella Eckerle, Pauline Vetter, Laurent Kaiser
334 [GO] 2021―May―17 Long COVID and the brain network of Proust's madeleine: targeting the olfactory pathway Eric GUEDJ, Françoise LAZARINI, Silvia MORBELLI, Mathieu CECCALDI, Charlotte HAUTEFORT, Aurélie KAS, et al. (+3)
335 [GO] 2021―May―15 Methodological evaluation of bias in observational COVID-19 studies on drug effectiveness: author's response M. Wolkewitz, M. von Cube, O. Martinuka
336 [GO] 2021―May―12 Spreading of a new SARS-CoV-2 N501Y spike variant in a new lineage Philippe COLSON, Anthony LEVASSEUR, Jeremy DELERCE, Lucile PINAULT, Pierre DUDOUET, Christian DEVAUX, et al. (+4)
337 [GO] 2021―May―10 Persistent COVID-19 symptoms are highly prevalent 6 months after hospitalization: results from a large prospective cohort Jade Ghosn, Lionel Piroth, Olivier Epaulard, Paul Le Turnier, France Mentré, Delphine Bachelet, Cédric Laouénan
338 [GO] 2021―May―10 Outbreak investigation of symptomatic SARS-COV-2 VOC 202012/01-lineage B.1.1.7 infection in healthcare workers, Italy Daniela Loconsole, Anna Sallustio, Marisa Accogli, Angela Leaci, Antonio Sanguedolce, Antonio Parisi, Maria Chironna
339 [GO] 2021―May―09 SARS-COV-2 antibody dynamics and B-cell memory response over-time in COVID-19 convalescent subjects Anat Achiron, Michael Gurevich, Rina Falb, Sapir Dreyer-Alster, Polina Sonis, Mathilda Mandel
340 [GO] 2021―May―09 How to interpret and use COVID-19 serology and immunology tests David S.Y. Ong, Paraskevi C. Fragkou, Valentijn A. Schweitzer, Roy F. Chemaly, Charalampos D. Moschopoulos, Chrysanthi Skevaki
341 [GO] 2021―May―09 Early antibody response in healthcare professionals after two doses of SARS-CoV-2 mRNA vaccine (BNT162b2) Julien Favresse, Jean-Louis Bayart, François Mullier, Jean-Michel Dogné, Mélanie Closset, Jonathan Douxfils
342 [GO] 2021―May―09 How the European In Vitro Diagnostic Regulation could negatively impact the European response to the next pandemic: an urgent call for action before May 2022 Pieter Vermeersch, Emmanuel André
343 [GO] 2021―May―06 Re: ‘methodological evaluation of bias in observational COVID-19 studies on drug effectiveness' by Wolkewitz et al Alessandro Cozzi-Lepri, Giovanni Guaraldi, Marianna Meschiari, Cristina Mussini
344 [GO] 2021―May―03 Antibody response to mRNA SARS-CoV-2 vaccine among kidney transplant recipients - Prospective cohort study Benaya Rozen-Zvi, Dafna Yahav, Timna Agur, Boris Zingerman, Haim Ben-Zvi, Alaa Atamna, et al. (+4)
345 [GO] 2021―Apr―29 Personalized prophylactic anticoagulation in hospitalized patients with Covid-19 - The role of anti-Xa monitoring Diamantis P. Kofteridis, Petros Ioannou, Eumorfia Kondili, Georgios Chamilos, Theodosios D. Filippatos
346 [GO] 2021―Apr―27 Clinical characteristics and factors associated with hospital admission or death in 43,103 adult outpatients with COVID-19 managed with the Covidom telesurveillance solution: a prospective cohort study Youri Yordanov, Aurélien Dinh, Alexandre Bleibtreu, Arthur Mensch, François-Xavier Lescure, Erwan Debuc, et al. (+62)
347 [GO] 2021―Apr―27 Efficacy and safety of tocilizumab in COVID-19 patients: A living systematic Review and meta-analysis: first update Imad M. Tleyjeh, Zakariya Kashour, Muhammad Riaz, Leslie Hassett, Viviane C. Veiga, Tarek Kashour
348 [GO] 2021―Apr―24 Prevalence and clinical significance of relative bradycardia at hospital admission in patients with Coronavirus Disease 2019 (COVID-19) Oliva A, Franchi C, Gatto MC, Galardo G, Pugliese F, Mastroianni CM
349 [GO] 2021―Apr―24 Disinfectant effectiveness against SARS-CoV-2 and influenza viruses present on human skin: model-based evaluation Ryohei Hirose, Risa Bandou, Hiroshi Ikegaya, Naoto Watanabe, Takuma Yoshida, Tomo Daidoji, et al. (+3)
350 [GO] 2021―Apr―24 Diagnostic accuracy of loop mediated isothermal amplification coupled to nanopore sequencing (LamPORE) for the detection of SARS-CoV-2 infection at scale in symptomatic and asymptomatic populations Anetta Ptasinska, Celina Whalley, Andrew Bosworth, Charlotte Poxon, Claire Bryer, Nicholas Machin, et al. (+35)
351 [GO] 2021―Apr―23 Long-term outcomes of patients following hospitalization for COVID-19: a prospective observational study Y. Meije, A. Duarte-Borges, X. Sanz, M. Clemente, Ribera A, L. Ortega, et al. (+75)
352 [GO] 2021―Apr―20 Not all COVID-19 pandemic waves are alike Pere Domingo, Virgina Pomar, Isabel Mur, Ivan Castellví, Héctor Corominas, Natividad de Benito
353 [GO] 2021―Apr―07 Seroprevalence of SARS-CoV-2 in Slovenia: results of two rounds of a nationwide population study on a probability-based sample, challenges and lessons learned Mario Poljak, Anja Oštrbenk Valenčak, Erik Štrumbelj, Polona Maver Vodičar, Vasja Vehovar, Katarina Resman Rus, et al. (+8)
354 [GO] 2021―Apr―02 Sex-biased clinical presentation and outcomes from COVID-19 Eileen P. Scully, Amita Gupta, Sabra L. Klein
355 [GO] 2021―Apr―02 Methodological evaluation of bias in observational COVID-19 studies on drug effectiveness Oksana Martinuka, Maja von Cube, Martin Wolkewitz
356 [GO] 2021―Apr―02 SARS-CoV-2 Antibodies and utility of point of care testing in Health Care Workers from a Spanish University Hospital in Madrid M. Rodríguez-Domínguez, B. Romero-Hernández, D. Marcos-Mencía, M. Fernandez-Escribano, M. Ferré-Masferrer, J.C. Galán, R. Cantón
357 [GO] 2021―Apr―02 The SARS-CoV-2 pandemic puts the spotlight on gender inequality in clinical research Mette Søgaard, Kristine Lilholt Nilsson, Evelina Tacconelli
358 [GO] 2021―Apr―02 SARS-CoV-2 specific T cell immunity in COVID-19 convalescent patients and unexposed controls measured by ex-vivo ELISpot assay Irene Cassaniti, Elena Percivalle, Federica Bergami, Antonio Piralla, Giuditta Comolli, Raffaele Bruno, et al. (+11)
359 [GO] 2021―Apr―02 Hydroxychloroquine in mild-to-moderate COVID-19: a placebo-controlled double blind trial Vincent Dubée, Pierre-Marie Roy, Bruno Vielle, Elsa Parot-Schinkel, Odile Blanchet, Astrid Darsonval, et al. (+12)
360 [GO] 2021―Apr―02 Community-acquired Pneumonia Severity Assessment Tools in Patients Hospitalized with COVID-19: a Validation and Clinical Applicability Study Felippe Lazar Neto, Lucas Oliveira Marino, Antoni Torres, Catia Cilloniz, Julio Flavio Meirelles Marchini, Julio Cesar Garcia de Alencar, et al. (+75)
361 [GO] 2021―Apr―02 Recommendations for accurate genotyping of SARS-CoV-2 using amplicon-based sequencing of clinical samples Slawomir Kubik, Ana Claudia Marques, Xiaobin Xing, Janine Silvery, Claire Bertelli, Flavio De Maio, et al. (+23)
362 [GO] 2021―Apr―02 14-Day survival among older adults with severe SARS-Cov2 infection treated with corticosteroid: a cohort study Gallay Laure, Tran Viet-Thi, Perrodeau Elodie, Vignier Nicolas, Mahevas Matthieu, Bisio Francesca, et al. (+52)
363 [GO] 2021―Mar―31 Acceptance of Covid-19 vaccine among healthcare personnel in India: A cross-sectional survey during the initial phase of vaccination Nikhil Singhania, Sanjana Kathiravan, Ashok Kumar Pannu
364 [GO] 2021―Mar―30 SARS-CoV-2 escape mutants and protective immunity from natural infections or immunizations Di Caro A, Cunha F, Petrosillo N, Beeching NJ, Ergonul O, Petersen E, Koopmans MPG
365 [GO] 2021―Mar―10 A real-life setting evaluation of the effect of remdesivir on viral load in COVID-19 patients admitted to a large tertiary center in Israel Elad Goldberg, Haim Ben Zvi, Liron Sheena, Summer Sofer, Ilan Krause, Ella H. Sklan, Amir Shlomai
366 [GO] 2021―Mar―09 Efficacy and safety of tocilizumab in COVID-19 patients: a living systematic review and meta-analysis-authors’ response Tarek Kashour, Imad M. Tleyjeh
367 [GO] 2021―Mar―06 Seroprevalence of SARS-CoV-2 in 1922 blood donors from the Lodi Red Zone and adjacent Lodi metropolitan and suburban area Irene Cassaniti, Elena Percivalle, Antonella Sarasini, Giuseppe Cambiè, Edoardo Vecchio Nepita, Roberta Maserati, et al. (+7)
368 [GO] 2021―Mar―02 Pulmonary long-term consequences of COVID-19 infections after hospital discharge J.R. Blanco, M.J. Cobos-Ceballos, F. Navarro, I. Sanjoaquin, F. Arnaiz de las Revillas, E. Bernal, et al. (+12)
369 [GO] 2021―Feb―27 Serious bradycardia and remdesivir for coronavirus 2019 (COVID-19): a new safety concerns Anthony Touafchia, Haleh Bagheri, Didier Carrié, Geneviève Durrieu, Agnès Sommet, François Montastruc
370 [GO] 2021―Feb―23 Prolonged SARS-CoV-2 cell culture replication in respiratory samples from patients with severe COVID-19 Maria Dolores Folgueira, Joanna Luczkowiak, Fátima Lasala, Alfredo Pérez-Rivilla, Rafael Delgado
371 [GO] 2021―Feb―21 Saliva for molecular detection of SARS-CoV-2 in school-aged children Hanan Al Suwaidi, Abiola Senok, Rupa Varghese, Zulfa Deesi, Hamda Khansaheb, Sabeel Pokasirakath, et al. (+4)
372 [GO] 2021―Feb―21 Clinical, virological and immunological features of a mild case of SARS-CoV-2 re-infection Pauline Vetter, Samuel Cordey, Manuel Schibler, Laure Vieux, Lena Despres, Florian Laubscher, et al. (+11)
373 [GO] 2021―Feb―17 'High prevalence of heterotopic ossification in critically ill patients with severe COVID-19' - Author’s reply Elisa Stoira, Alessandro Felice Chiesa, Luigia Elzi
374 [GO] 2021―Feb―17 Onset, duration and unresolved symptoms, including smell and taste changes, in mild COVID-19 infections. A cohort study in Israeli patients Hadar Klein, Kim Asseo, Noam Karni, Yuval Benjamini, Ran Nir-Paz, Mordechai Muszkat, et al. (+2)
375 [GO] 2021―Feb―17 Investigating the impact of COVID-19 on primary care antibiotic prescribing in North West London across two epidemic waves Nina Zhu, Paul Aylin, Timothy Rawson, Mark Gilchrist, Azeem Majeed, Alison Holmes
376 [GO] 2021―Feb―17 Multicenter evaluation of the Panbio™ COVID-19 rapid antigen-detection test for the diagnosis of SARS-CoV-2 infection Paloma Merino, Jesús Guinea, Irene Muñoz-Gallego, Patricia González-Donapetry, Juan Carlos Galán, Nerea Antona, et al. (+26)
377 [GO] 2021―Feb―16 Early detection of SARS-CoV-2 infection cases or outbreaks at nursing homes by targeted wastewater tracking Laura Davó, Raimundo Seguí, Pilar Botija, María José Beltrán, Eliseo Albert, Ignacio Torres, et al. (+5)
378 [GO] 2021―Feb―09 Prevalence and impact factors of recurrent positive SARS-CoV-2 detection in 599 hospitalized COVID-19 patients Chun Gao, Li Zhu, Cheng Cheng Jin, Yi Xin Tong, Ai Tang Xiao, Sheng Zhang
379 [GO] 2021―Feb―06 Re: ‘Efficacy and safety of tocilizumab in COVID-19 patients: A living systematic review and meta-analysis' by Tleyjeh et al David Koeckerling, Daniel Pan, Joseph Barker
380 [GO] 2021―Feb―03 Preventive measures for accompanying caregivers of children in paediatric health care during the COVID-19 pandemic - Walking an ethical Tightrope Hanna Schmid, Ulrich Heininger, Danielle Vuichard-Gysin, Andreas Widmer, Julia Bielicki
381 [GO] 2021―Feb―03 Effect of the COVID-19 pandemic on antibiotic use in primary care Germán Peñalva, Regina Sandra Benavente, María Antonia Pérez-Moreno, María Dolores Pérez-Pacheco, Alejandro Pérez-Milena, José Murcia, José Miguel Cisneros
382 [GO] 2021―Feb―03 Corrigendum to “Review of trials currently testing treatment and prevention of COVID-19” [Clin Microbiol Infect 26.8 (2020) 988-998] Paraskevi C. Fragkou, Drifa Belhadi, Nathan Peiffer-Smadja, Charalampos D. Moschopoulos, François-Xavier Lescure, Hannah Janocha, et al. (+6)
383 [GO] 2021―Jan―30 A global analysis on replacement of genetic variants of SARS-CoV-2 in associate with containment capacity and changes in disease severity Zigui Chen, Ka Chun Chong, Martin C.S. Wong, Siaw S. Boon, Junjie Huang, Maggie H. Wang, et al. (+3)
384 [GO] 2021―Jan―29 Interpretation of SARS-CoV-2 replication according to RT-PCR crossing threshold value Stéphane Marot, Vincent Calvez, Martine Louet, Anne-Geneviève Marcelin, Sonia Burrel
385 [GO] 2021―Jan―22 Defining the role of asymptomatic and pre-symptomatic SARS-CoV-2 transmission - a living systematic review Xueting Qiu, Ali Ihsan Nergiz, Alberto Enrico Maraolo, Isaac I. Bogoch, Nicola Low, Muge Cevik
386 [GO] 2021―Jan―21 Re: ‘clinical course and outcomes of critically ill patients with COVID-19 infection: a systematic review' by Serafim et al Jed Lipes, Stephen Su Yang
387 [GO] 2021―Jan―20 Awareness, acceptance, and adoption of the national digital contact tracing tool post COVID-19 lockdown among visitors of a public hospital in Singapore Zhilian Huang, Huiling Guo, Hannah YeeFen Lim, Angela Chow
388 [GO] 2021―Jan―20 Better prognosis in females with severe COVID-19 pneumonia: possible role of inflammation as potential mediator Cristina Mussini, Alessandro Cozzi-Lepri, Marianna Menozzi, Marianna Meschiari, Erica Franceschini, Carlotta Rogati, et al. (+49)
389 [GO] 2021―Jan―20 Antibody persistence in the first six months following SARS-CoV-2 infection among hospital workers: a prospective longitudinal study Arnaud G. L’Huillier, Benjamin Meyer, Diego O. Andrey, Isabelle Arm-Vernez, Stephanie Baggio, Arnaud Didierlaurent, et al. (+11)
390 [GO] 2021―Jan―19 Therapeutic strategies for severe COVID-19: a position paper from the Italian Society of Infectious and Tropical Diseases (SIMIT) Cristina Mussini, Marco Falcone, Silvia Nozza, Caterina Sagnelli, Roberto Parrella, Marianna Meschiari, et al. (+17)
391 [GO] 2021―Jan―19 Prophylaxis for COVID-19: a systematic review Mikaela Smit, Annalisa Marinosci, Thomas Agoritsas, Nathan Ford, Alexandra Calmy
392 [GO] 2021―Jan―18 High prevalence of heterotopic ossification in critically ill patients with severe COVID-19 Elisa Stoira, Luigia Elzi, Carla Puligheddu, Riccardo Garibaldi, Camelia Voinea, Alessandro Felice Chiesa
393 [GO] 2021―Jan―18 SARS-CoV-2 nucleocapsid-protein and ultrastructural modifications in small bowel of a four week negative COVID-19 patient Roberta Rizzo, Luca Maria Neri, Carolina Simioni, Daria Bortolotti, Savino Occhionorelli, Giorgio Zauli, et al. (+7)
394 [GO] 2021―Jan―18 Re: ‘High prevalence of heterotopic ossification in critically ill patients with severe COVID-19' by Stoira et al Nicolas de l’Escalopier, Laurent Mathieu, Christophe Duret, Sébastien Banzet, François Genêt, Marjorie Salga
395 [GO] 2021―Jan―14 Six-month antibody response to SARS-CoV-2 in healthcare workers assessed by virus neutralisation and commercial assays Mary-Anne Trabaud, Jean-Baptiste Fassier, Muriel Rabilloud, Kahina Saker, Carole Langlois-Jacques, Nicolas Guibert, et al. (+52)
396 [GO] 2021―Jan―12 COVID-19 case fatality rates can be highly misleading in resource poor and fragile nations: the case of Yemen Mohammed Noushad, Inas Shakeeb Al Saqqaf
397 [GO] 2021―Jan―12 Outbreak of Candida auris infection in a COVID-19 hospital in Mexico Hiram Villanueva-Lozano, Rogelio de J. Treviño-Rangel, Gloria M. González, María Teresa Ramírez-Elizondo, Reynaldo Lara-Medrano, Mary Cruz Aleman-Bocanegra, et al. (+5)
398 [GO] 2021―Jan―09 Evaluation of a rapid antigen test (Panbio™ COVID-19 Ag rapid test device) for SARS-CoV-2 detection in asymptomatic close contacts of COVID-19 patients Ignacio Torres, Sandrine Poujois, Eliseo Albert, Javier Colomina, David Navarro
399 [GO] 2021―Jan―09 Gender disparities in COVID-19 clinical trial leadership Muge Cevik, Syed Arefinul Haque, Jennifer Manne-Goehler, Krutika Kuppalli, Paul E. Sax, Maimuna S. Majumder, Chloe Orkin
400 [GO] 2021―Jan―09 Self-reported symptoms in healthy young adults to predict potential COVID-19 disease Maya Nitecki, Boris Taran, Itay Ketko, Gil Geva, Roey Yosef, Itay Toledo, et al. (+6)
401 [GO] 2021―Jan―09 Long-term persistence of olfactory and gustatory disorders in COVID-19 patients Nhu Ngoc Nguyen, Van Thuan Hoang, Jean-Christophe Lagier, Didier Raoult, Philippe Gautret
402 [GO] 2021―Jan―09 Antibiotic prescribing in patients with COVID-19: rapid review and meta-analysis Bradley J. Langford, Miranda So, Sumit Raybardhan, Valerie Leung, Jean-Paul R. Soucy, Duncan Westwood, et al. (+2)
403 [GO] 2021―Jan―09 Seroprevalence of SARS-CoV-2 antibodies In 2115 blood donors from Romania Tudor Rares Olariu, Rodica Lighezan, Sorin Ursoniu, Alina Cristiana Craciun, Ana Alexandra Paduraru, Maria Alina Lupu
404 [GO] 2021―Jan―09 The importance of anosmia, ageusia and age in community presentation of symptomatic and asymptomatic SARS-CoV-2 infection in Louisiana, USA; a cross-sectional prevalence study Amy K. Feehan, Daniel Fort, Cruz Velasco, Jeffrey H. Burton, Julia Garcia-Diaz, Eboni G. Price-Haywood, et al. (+3)
405 [GO] 2021―Jan―09 Testing SARS-CoV-2 vaccine efficacy through deliberate natural viral exposure Nir Eyal, Marc Lipsitch
406 [GO] 2021―Jan―02 Re-evaluating positive serum samples for SARS-CoV-2-specific IgA and IgG antibodies using an in-house serological assay Margherita Cacaci, Giulia Menchinelli, Rosalba Ricci, Flavio De Maio, Melinda Mariotti, Riccardo Torelli, et al. (+4)
407 [GO] 2020―Dec―31 Decreased prevalence rate of respiratory pathogens in hospitalized patients during the COVID-19 pandemic: possible role for public health containment measures? Yonatan Oster, Ayelet Michael-Gayego, Mila Rivkin, Leonid Levinson, Dana G. Wolf, Ran Nir-Paz
408 [GO] 2020―Dec―13 Risk factors associated with Covid-19-associated pulmonary aspergillosis in ICU patients: a French multicentric retrospective cohort Sarah Dellière, Emmanuel Dudoignon, Sofiane Fodil, Sebastian Voicu, Magalie Collet, Pierre-Antoine Oillic, et al. (+10)
409 [GO] 2020―Dec―11 Long COVID-19 - it’s not over until? Dana Yelin, Ili Margalit, Dafna Yahav, Michael Runold, Judith Bruchfeld
410 [GO] 2020―Dec―11 Covid-19 experts appearing on Japanese television: their characteristics and financial conflicts of interest with pharmaceutical companies Anju Murayama, Akihiko Ozaki, Hiroaki Saito, Toyoaki Sawano, Ranjit Sah, Tetsuya Tanimoto
411 [GO] 2020―Dec―11 Effect of hydroxychloroquine pre-exposure on infection with SARS-CoV-2 in rheumatic disease patients: A population-based cohort study Sun-Young Jung, Myo-Song Kim, Min-Chul Kim, Seong-Ho Choi, Jin-Won Chung, Sang Tae Choi
412 [GO] 2020―Dec―09 Detection of SARS-CoV-2 N-antigen in blood during acute COVID-19 provides a sensitive new marker and new testing alternatives Quentin LE. Hingrat, Benoit Visseaux, Cédric Laouenan, Sarah Tubiana, Lila Bouadma, Yazdan Yazdanpanah, et al. (+299)
413 [GO] 2020―Dec―08 Corticosteroids in patients hospitalised for COVID-19 pneumonia who require oxygen: observational comparative study using routine care data Laurence Maulin, Stéphanie Martinez, Viet-Thi Tran, Matthieu Mahévas, Firouze Bani-Sadr, Olivier Robineau, et al. (+121)
414 [GO] 2020―Dec―05 Definitions for COVID-19 reinfection, relapse and PCR re-positivity Dafna Yahav, Dana Yelin, Isabella Eckerle, Christiane S. Eberhardt, Jianwei Wang, Bin Cao, Laurent Kaiser
415 [GO] 2020―Dec―05 Prevalence of SARS-CoV-2 IgG antibodies in a large prospective cohort study of elite football players in Germany (May-June 2020): implications for a testing protocol in asymptomatic individuals and estimation of the rate of undetected cases Dietrich Mack, Barbara Christine Gärtner, Annika Rössler, Janine Kimpel, Katrin Donde, Oliver Harzer, et al. (+3)
416 [GO] 2020―Dec―02 No evidence of SARS-CoV-2 circulation in HIV-infected patients between December 2019 and February 2020 in Rome, Italy Francesca Lombardi, Simone Belmonti, Rosalba Ricci, Alberto Borghetti, Massimiliano Fabbiani, Arturo Ciccullo, et al. (+2)
417 [GO] 2020―Nov―28 Prevalence of SARS-CoV-2 IgG antibodies in an area of North-eastern Italy with a high incidence of COVID-19 cases: a population-based study Paola Stefanelli, Antonino Bella, Giorgio Fedele, Serena Pancheri, Pasqualina Leone, Paola Vacca, et al. (+16)
418 [GO] 2020―Nov―28 Impact of the COVID-19 pandemic on the diagnosis, management and prognosis of infective endocarditis Laura Escolà-Vergé, Guillermo Cuervo, Arístides de Alarcón, Dolores Sousa, Laura Varela Barca, Nuria Fernández-Hidalgo, et al. (+85)
419 [GO] 2020―Nov―25 COVID-19 and geographical area of origin Norman FF, C. Crespillo-Andújar, J.A. Pérez-Molina, Comeche B, Chamorro S, B. Monge-Maillo, et al. (+32)
420 [GO] 2020―Nov―25 Antibiotic use in the COVID-19 crisis in Spain Bruno Gonzalez-Zorn
421 [GO] 2020―Nov―20 Universal PCR screening for COVID-19 in asymptomatic patients on admission Itaru Nakamura, Takao Itoi
422 [GO] 2020―Nov―20 Antibody response using six different serological assays in a completely PCR-tested community after a COVID-19 outbreak - The CoNAN study Sebastian Weis, André Scherag, Michael Baier, Michael Kiehntopf, Thomas Kamradt, Steffi Kolanos, et al. (+40)
423 [GO] 2020―Nov―13 Field evaluation of a rapid antigen test (Panbio™ COVID-19 Ag Rapid Test Device) for COVID-19 diagnosis in primary healthcare centers Eliseo Albert, Ignacio Torres, Felipe Bueno, Dixie Huntley, Estefanía Molla, Miguel Ángel Fernández-Fuentes, et al. (+8)
424 [GO] 2020―Nov―13 Neurological manifestations associated with COVID-19: a multicentric registry Elodie Meppiel, Nathan Peiffer-Smadja, Alexandra Maury, Imen Bekri, Cécile Delorme, Virginie Desestret, et al. (+11)
425 [GO] 2020―Nov―11 Nucleic-acid-amplification tests from respiratory samples for the diagnosis of coronavirus infections: systematic review and meta-analysis Mona Mustafa Hellou, Anna Górska, Fulvia Mazzaferri, Eleonora Cremonini, Elisa Gentilotti, Pasquale De Nardo, et al. (+4)
426 [GO] 2020―Nov―06 Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients: a systematic review and meta-analysis' - Author’s reply Thibault Fiolet, Anthony Guihur, Mathieu E. Rebeaud, Matthieu Mulot, Nathan Peiffer-Smadja, Yahya Mahamat-Saleh
427 [GO] 2020―Nov―05 Efficacy and safety of tocilizumab in COVID-19 patients: A living systematic review and meta-analysis Imad M. Tleyjeh, Zakariya Kashour, Moussab Damlaj, Muhammad Riaz, Haytham Tlayjeh, Mustafa Altannir, et al. (+5)
428 [GO] 2020―Nov―05 Saliva collected in universal transport media is an effective, simple and high-volume amenable method to detect SARS-CoV-2 Byron M. Berenger, John M. Conly, Kevin Fonseca, Jia Hu, Thomas Louie, Angela R. Schneider, et al. (+4)
429 [GO] 2020―Nov―05 SARS-CoV-2 infection: the environmental endurance of the virus can be influenced by the increase of temperature Fabio Magurano, Melissa Baggieri, Antonella Marchi, Giovanni Rezza, Loredana Nicoletti
430 [GO] 2020―Nov―02 Impact of COVID-19 on maternal and neonatal outcomes: a systematic review and meta-analysis Francesca Di Toro, Mattheus Gjoka, Giovanni Di Lorenzo, Francesco De Seta, Gianpaolo Maso, Francesco Maria Risso, et al. (+5)
431 [GO] 2020―Nov―02 Intrahost non-synonymous diversity at a neutralising antibody epitope of SARS-CoV-2 spike protein N-terminal domain Jonathan Daniel Ip, Kin-Hang Kok, Wan-Mui Chan, Allen Wing-Ho Chu, Wai-Lan Wu, Cyril Chik-Yan Yip, et al. (+8)
432 [GO] 2020―Oct―31 A Call for Antimicrobial Stewardship in Patients with COVID-19: A Nationwide Cohort Study in Korea Dong Hoon Shin, Minsun Kang, Kyoung-Ho Song, Jaehun Jung, Eu Suk Kim, Hong Bin Kim
433 [GO] 2020―Oct―28 Re -Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients: a systematic review and meta-analysis Nicolas Vedrines, Anne-Typhaine Bouthors, Stéphane Gayet, Alexis Lacout
434 [GO] 2020―Oct―24 Management of bacteriological specimens of patients suffering from coronavirus disease 2019 (COVID-19) M. Hogardt, S. Besier, L. Vorbeck, S. Göttig, T. Wichelhaus, D. Villinger, et al. (+4)
435 [GO] 2020―Oct―24 Secondary Infections in Patients Hospitalized with COVID-19: Incidence and Predictive Factors Marco Ripa, Laura Galli, Andrea Poli, Chiara Oltolini, Vincenzo Spagnuolo, Andrea Mastrangelo, et al. (+76)
436 [GO] 2020―Oct―24 SARS-CoV-2 seroprevalence worldwide: a systematic review and meta-analysis A. Rostami, M. Sepidarkish, M. Leeflang, S.M. Riahi, M. Nourollahpour Shiadeh, S. Esfandyari, et al. (+3)
437 [GO] 2020―Oct―23 Clinical course and outcomes of critically-ill patients with COVID-19 infection: A systematic review Rodrigo B. Serafim, Pedro Póvoa, Vicente Souza-Dantas, André C. Kalil, Jorge I.F. Salluh
438 [GO] 2020―Oct―23 Migrant status, ethnicity and COVID-19: More accurate European data are greatly needed Maria Melchior, Annabel Desgrées du Loû, Anne Gosselin, Geetanjali D. Datta, Mabel Carabali, Joanna Merckx, Jay S. Kaufman
439 [GO] 2020―Oct―23 Risk assessment for rationalising the use of personal protective equipment for SARS-CoV2 in healthcare settings with special focus on low- and middle-income settings Ioana D. Olaru, Rashida A. Ferrand, Marcelyn T. Magwenzi, Valerie Robertson, Vimbainashe Musenyereki, Katharina Kranzer
440 [GO] 2020―Oct―21 Rational for meta-analysis and randomized treatment: the COVID-19 example Didier Raoult
441 [GO] 2020―Oct―20 Has the door closed on hydroxychloroquine for SARS-COV-2? Mical Paul
442 [GO] 2020―Oct―17 'Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients' - Author’s reply Thibault Fiolet, Anthony Guihur, Mathieu E. Rebeaud, Matthieu Mulot, Nathan Peiffer-Smadja, Yahya Mahamat-Saleh
443 [GO] 2020―Oct―14 Outcomes of persons with COVID-19 in hospitals with and without standard treatment with (Hydroxy)chloroquine E.J.G. Peters, D. Collard, S. Van Assen, M. Beudel, M.K. Bomers, J. Buijs, et al. (+18)
444 [GO] 2020―Oct―14 Specificity and positive predictive value of SARS-CoV-2 nucleic acid amplification testing in a low prevalence setting Jordan P. Skittrall, Michael Wilson, Anna A. Smielewska, Surendra Parmar, Mary D. Fortune, Dominic Sparkes, et al. (+3)
445 [GO] 2020―Oct―13 Outcome of hospitalized patients with COVID-19 pneumonia treated with high-dose immunoglobulin therapy in a prospective case series Esteban Reynaga, Jorge Carrillo, Jose Ramón Santos, Silvia Roure, Lourdes Mateu, Roger Paredes, et al. (+3)
446 [GO] 2020―Oct―12 Overall decrease of SARS-CoV-2 viral load and reduction of clinical burden: the experience of a Northern Italy hospital Chiara Piubelli, Michela Deiana, Elena Pomari, Ronaldo Silva, Zeno Bisoffi, Fabio Formenti, et al. (+3)
447 [GO] 2020―Oct―10 A whole blood test to measure SARS-CoV-2 specific response in COVID-19 patients Linda Petrone, Elisa Petruccioli, Valentina Vanini, Gilda Cuzzi, Saeid Najafi Fard, Tonino Alonzi, et al. (+14)
448 [GO] 2020―Oct―10 Cardiovascular magnetic resonance imaging in children with pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 and heart dysfunction Luis M. Prieto, Belén Toral, Ana LLorente, David Coca, Daniel Blázquez
449 [GO] 2020―Oct―09 Understanding the role of bacterial and fungal infection in COVID-19 Timothy M. Rawson, Richard C. Wilson, Alison Holmes
450 [GO] 2020―Oct―07 Seroprevalence of SARS-CoV-2 immunoglobulin antibodies in Wuhan, China: part of the city-wide massive testing campaign Yunbao Pan, Xinran Li, Gui Yang, Junli Fan, Yueting Tang, Xiaoyue Hong, et al. (+7)
451 [GO] 2020―Oct―05 Follow-up of adults with non-critical COVID-19 two months after symptoms' onset Claudia Carvalho-Schneider, Emeline Laurent, Adrien Lemaignen, Emilie Beaufils, Céline Bourbao-Tournois, Saïd Laribi, et al. (+7)
452 [GO] 2020―Oct―05 Accuracy of a nucleocapsid protein antigen rapid test in the diagnosis of SARS-CoV-2 infection Bo Diao, Kun Wen, Ji Zhang, Jian Chen, Chao Han, Yongwen Chen, et al. (+4)
453 [GO] 2020―Oct―03 SARS-CoV-2 ACE-Receptor detection in the placenta throughout pregnancy Carole Gengler, Estelle Dubruc, Guillaume Favre, Gilbert Greub, Laurence de Leval, David Baud
454 [GO] 2020―Oct―01 Recommendations for antibacterial therapy in adults with COVID-19 - An evidence based guideline Elske Sieswerda, Mark G.J. De Boer, Marc M.J. Bonten, Wim G. Boersma, René E. Jonkers, Roel M. Aleva, et al. (+7)
455 [GO] 2020―Oct―01 Extremely Low Prevalence of Asymptomatic COVID-19 Among Healthcare Workers Caring for COVID-19 Patients in Israeli Hospitals: a Cross-sectional Study Elizabeth Temkin, Elizabeth Temkin, Mitchell J. Schwaber, Ester Solter, Azza Vaturi, Dafna Chen, et al. (+35)
456 [GO] 2020―Sep―30 What is the ‘new normal’ in Surgical Procedures in the Era of COVID-19? Cansu Cimen, Şiran Keske, Önder Ergönül
457 [GO] 2020―Sep―29 Low-to-moderate dose corticosteroids treatment in hospitalized adults with COVID-19 Zhibo Liu, Xia Li, Guohui Fan, Fei Zhou, Yeming Wang, Lixue Huang, et al. (+12)
458 [GO] 2020―Sep―29 SARS-CoV-2 variant tracing within the first COVID-19 clusters in Northern Germany Susanne Pfefferle, Thomas Günther, Robin Kobbe, Manja Czech-Sioli, Dominic Nörz, René Santer, et al. (+11)
459 [GO] 2020―Sep―29 What is the optimal usage of Covid-19 convalescent plasma donations? Focosi Daniele, Tuccori Marco, Antonelli Guido, Maggi Fabrizio
460 [GO] 2020―Sep―29 Re: Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients' by Fiolet et al Chia Siang Kow, Syed Shahzad Hasan
461 [GO] 2020―Sep―29 Treatment of COVID-19 with convalescent plasma' - Author’s reply Denise J. Wooding, Horacio Bach
462 [GO] 2020―Sep―25 Re: 'effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients' by Fiolet et al Matthieu Million, Yanis Roussel, Jean-Christophe Lagier, Didier Raoult
463 [GO] 2020―Sep―25 Re: 'Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients' by Fiolet et al Alexis Lacout, Pierre Yves Marcy, Christian Perronne
464 [GO] 2020―Sep―23 National case fatality rates of the COVID-19 pandemic Önder Ergönül, Merve Akyol, Cem Tanrıöver, Henning Tiemeier, Eskild Petersen, Nicola Petrosillo, Mehmet Gönen
465 [GO] 2020―Sep―23 Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study Qiutang Xiong, Ming Xu, Jiao Li, Yinghui Liu, Jixiang Zhang, Yu Xu, Weiguo Dong
466 [GO] 2020―Sep―23 Effects of tocilizumab on mortality in hospitalized patients with COVID-19: A multicenter cohort study Javier Martínez-Sanz, Alfonso Muriel, Raquel Ron, Sabina Herrera, José A. Pérez-Molina, Santiago Moreno, Sergio Serrano-Villar
467 [GO] 2020―Sep―23 Performance of a novel diagnostic assay for rapid SARS-CoV-2 antigen detection in nasopharynx samples Flora Marzia Liotti, Giulia Menchinelli, Eleonora Lalle, Ivana Palucci, Simona Marchetti, Francesca Colavita, et al. (+7)
468 [GO] 2020―Sep―23 High-speed large-scale automated isolation of SARS-CoV-2 from clinical samples using miniaturized co-culture coupled to high-content screening Rania Francis, Marion Le Bideau, Priscilla Jardot, Clio Grimaldier, Didier Raoult, Jacques Yaacoub Bou Khalil, Bernard La Scola
469 [GO] 2020―Sep―22 Surging publications on the COVID-19 pandemic Guanqiao Li, Yangzhong Zhou, Junyi Ji, Xiaozhen Liu, Qiao Jin, Linqi Zhang
470 [GO] 2020―Sep―22 Efficacy of corticosteroid treatment for hospitalized patients with severe COVID-19: a multicenter study Michele Bartoletti, Lorenzo Marconi, Luigia Scudeller, Livia Pancaldi, Sara Tedeschi, Maddalena Giannella, et al. (+85)
471 [GO] 2020―Sep―16 SARS-CoV-2 antibodies in healthcare workers in a large university hospital, Kerala, India Anil Kumar, Dipu Sathyapalan, Arya Ramachandran, Kiran Subhash, Lalitha Biswas, K.V. Beena
472 [GO] 2020―Sep―10 Detection and infectivity potential of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) environmental contamination in isolation units and quarantine facilities Amir Ben-Shmuel, Tal Brosh-Nissimov, Itai Glinert, Elad Bar-David, Assa Sittner, Reut Poni, et al. (+14)
473 [GO] 2020―Sep―10 Sample pooling for SARS-COV-2 RT-PCR screening Adolfo de Salazar, Antonio Aguilera, Rocio Trastoy, Ana Fuentes, Juan Carlos Alados, Manuel Causse, et al. (+21)
474 [GO] 2020―Sep―09 When two for the price of one isn’t a bargain: Estimating prevalence and microbiology of bacterial co-infections in patients with COVID-19 J.T. Thaden, S.A. Maskarinec
475 [GO] 2020―Sep―09 Impact of convalescent and nonimmune plasma on mortality of patients with COVID-19. A potential role for antithrombin Carmine Gazzaruso, Cinzia Valenti, Adriana Coppola, Pietro Gallotti
476 [GO] 2020―Sep―07 Factors associated with asymptomatic infection in health-care workers with SARS-CoV-2 infection in Wuhan, China: a multi-center retrospective cohort study Shuai Zhang, Mengfei Guo, Feng Wu, Nian Xiong, Yanling Ma, Zhihui Wang, et al. (+4)
477 [GO] 2020―Sep―06 Compliance with personal protective equipment to protect healthcare workers during COVID-19: ancillary workers count too Liang En Wee, Jean Xiang Ying, Sim, Edwin Philip Conceicao, May Kyawt Aung, Ian Mathias Ng, Moi Lin Ling
478 [GO] 2020―Sep―06 The kinetics of viral load and antibodiesto SARS-CoV-2 Jiufeng Sun, Xi Tang, Ru Bai, Chumin Liang, Lilian Zeng, Huifang Lin, et al. (+13)
479 [GO] 2020―Sep―06 Detection of SARS-CoV-2 in nasopharynx according to clinical phenotype of affected patients Francesca Valent, Antonio Di Chiara
480 [GO] 2020―Sep―03 Football and COVID-19 risk: correlation is not causation Fares Ayoub, Toshiro Sato, Atsushi Sakuraba
481 [GO] 2020―Sep―03 Pandemic preparedness of an academic medical center in the Republic of Korea Julia Ah-Reum An, Kyoung-Ho Song, Eu Suk Kim, Ruby Kwak, Jongtak Jung, Ji Young Park, et al. (+9)
482 [GO] 2020―Aug―27 Treatment with tocilizumab or corticosteroids for COVID-19 patients with hyperinflammatory state: a multicentre cohort study (SAM-COVID-19) Jesús Rodríguez-Baño, Jerónimo Pachón, Jordi Carratalà, Pablo Ryan, Inmaculada Jarrín, María Yllescas, et al. (+2)
483 [GO] 2020―Aug―26 Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients: a systematic review and meta-analysis Thibault Fiolet, Anthony Guihur, Mathieu Rebeaud, Matthieu Mulot, Nathan Peiffer-Smadja, Yahya Mahamat-Saleh
484 [GO] 2020―Aug―21 More than loss of taste and smell: burning watering eyes in coronavirus disease 19 (COVID-19) Alexander C. Rokohl, Niklas Loreck, Philomena A. Wawer Matos, Sarah Zwingelberg, Max Augustin, Felix Dewald, et al. (+4)
485 [GO] 2020―Aug―20 Epidemiological and clinical characteristics of SARS-CoV-2 infections at a testing site in Berlin, Germany, March and April 2020 - A cross-sectional study Friederike Maechler, Maximilian Gertler, Julia Hermes, Welmoed van Loon, Frank Schwab, Brar Piening, et al. (+13)
486 [GO] 2020―Aug―19 Co-infection with other respiratory pathogens in COVID-19 patients Andrea Calcagno, Valeria Ghisetti, Elisa Burdino, Mattia Trunfio, Tiziano Allice, Lucio Boglione, et al. (+2)
487 [GO] 2020―Aug―18 Relative bradycardia in patients with coronavirus disease 2019 (COVID-19) Gioele Capoferri, Michael Osthoff, Adrian Egli, Marcel Stoeckle, Stefano Bassetti
488 [GO] 2020―Aug―18 Clinical course and factors associated with outcomes among 1904 patients hospitalized with COVID-19 in Germany: an observational study Irit Nachtigall, Pavlina Lenga, Katarzyna Jóźwiak, Petra Thürmann, Andreas Meier-Hellmann, Ralf Kuhlen, et al. (+6)
489 [GO] 2020―Aug―18 Impact of COVID-19 pandemic on tuberculosis care in India Aliabbas.A. Husain, Tanya M. Monaghan, Rajpal Singh Kashyap
490 [GO] 2020―Aug―18 Proactive screening approach for SARS-CoV-2 among healthcare workers Yonatan Oster, Dana G. Wolf, Karen Olshtain-Pops, Zeev Rotstein, Carmela Schwartz, Shmuel Benenson
491 [GO] 2020―Aug―15 Clinical characteristics, management and in-hospital mortality of patients with COVID-19 In Genoa, Italy Antonio Vena, Daniele Roberto Giacobbe, Antonio Di Biagio, Malgorzata Mikulska, Lucia Taramasso, Andrea De Maria, et al. (+176)
492 [GO] 2020―Aug―14 A well-controlled Covid-19 cluster in a semi-closed adolescent psychiatry inpatient facility Anne Tilmanne, Gabrielle De Crombrugghe, Mouna Al-Husni Al-Keilani, Guillaume Le Loc’h, Véronique Delvenne, Pierre R. Smeesters
493 [GO] 2020―Aug―11 Treatment of COVID-19 with convalescent plasma: lessons from past coronavirus outbreaks Denise J. Wooding, Horacio Bach
494 [GO] 2020―Aug―08 Development and validation of a prediction model for severe respiratory failure in hospitalized patients with SARS-Cov-2 infection: a multicenter cohort study (PREDI-CO study) Michele Bartoletti, Maddalena Giannella, Luigia Scudeller, Sara Tedeschi, Matteo Rinaldi, Linda Bussini, et al. (+88)
495 [GO] 2020―Aug―07 Homeless people hospitalized with COVID-19 in Brussels Loïc Schrooyen, Marc Delforge, Faustine Lebout, Thibaut Vanbaelen, Amaryl Lecompte, Nicolas Dauby
496 [GO] 2020―Aug―07 Stigma at the time of the COVID-19 pandemic Simone Villa, Ernesto Jaramillo, Davide Mangioni, Alessandra Bandera, Andrea Gori, Mario Carlo Raviglione
497 [GO] 2020―Aug―06 Thermal treatment of nasopharyngeal samples prior to cobas® SARS-CoV-2 testing Todd M. Pryce, Peter A. Boan, Ian D. Kay, James P. Flexman
498 [GO] 2020―Aug―05 Invasive aspergillosis in patients with severe COVID-19 pneumonia Marie Helleberg, Morten Steensen, Maiken Cavling Arendrup
499 [GO] 2020―Aug―04 Characteristics and predictors of death among 4,035 consecutively hospitalized patients with COVID-19 in Spain Juan Berenguer, Pablo Ryan, Jesús Rodríguez-Baño, Inmaculada Jarrín, Jordi Carratalà, Jerónimo Pachón, et al. (+2)
500 [GO] 2020―Jul―31 Incidence of co-infections and superinfections in hospitalised patients with COVID-19: a retrospective cohort study Carolina Garcia-Vidal, Gemma Sanjuan, Estela Moreno-García, Pedro Puerta-Alcalde, Nicole Garcia-Pouton, Mariana Chumbita, et al. (+39)
501 [GO] 2020―Jul―31 Antibody response against SARS-CoV-2 spike protein and nucleoprotein evaluated by 4 automated immunoassays and 3 ELISAs Jan Van Elslande, Bram Decru, Stijn Jonckheere, Eric Van Wijngaerden, Els Houben, Patricia Vandecandelaere, et al. (+7)
502 [GO] 2020―Jul―28 Evaluating the newly developed BioFire® COVID-19 test for SARS-Cov-2 molecular detection Flora Marzia Liotti, Giulia Menchinelli, Simona Marchetti, Grazia Angela Morandotti, Maurizio Sanguinetti, Brunella Posteraro, Paola Cattani
503 [GO] 2020―Jul―24 CT lung lesions as predictors of early death or ICU admission in COVID-19 patients Yvon Ruch, Charlotte Kaeuffer, Mickael Ohana, Aissam Labani, Thibaut Fabacher, Pascal Bilbault, et al. (+6)
504 [GO] 2020―Jul―24 Evolution of viral quasispecies during SARS-CoV-2 infection A. Jary, V. Leducq, I. Malet, S. Marot, E. Klement-Frutos, E. Teyssou, et al. (+9)
505 [GO] 2020―Jul―23 Personal protective equipment protecting healthcare workers in the Chinese epicenter of COVID-19 Yi Zhao, Wenhua Liang, Yan Luo, Ying Chen, Peng Liang, Ran Zhong, et al. (+2)
506 [GO] 2020―Jul―23 Celebrating Eid-ul-Adha in the era of COVID-19 pandemic in Pakistan: potential threats and precautionary measures Tauqeer Hussain Mallhi, Yusra Habib Khan, Nasser Hadal Alotaibi, Abdulaziz Ibrahim Alzarea, Nida Tanveer, Amjad Khan
507 [GO] 2020―Jul―23 Viable SARS-CoV-2 in various specimens from COVID-19 patients Hye Won Jeong, Se-Mi Kim, Hee-Sung Kim, Young-Il Kim, Jun Hyoung Kim, Jun Yeon Cho, et al. (+6)
508 [GO] 2020―Jul―23 Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis Bradley J. Langford, Miranda So, Sumit Raybardhan, Valerie Leung, Duncan Westwood, Derek R. MacFadden, et al. (+2)
509 [GO] 2020―Jul―18 Low prevalence of active COVID-19 in Slovenia: a nationwide population study on a probability-based sample Polona Maver Vodičar, Anja Oštrbenk Valenčak, Blaž Zupan, Tatjana Avšič Županc, Slavko Kurdija, Miša Korva, et al. (+6)
510 [GO] 2020―Jul―18 Non-invasive saliva specimens for the diagnosis of COVID-19: caution in mild outpatient cohorts with low prevalence Keira Skolimowska, Michael Rayment, Rachael Jones, Pinglawathee Madona, Luke SP. Moore, Paul Randell
511 [GO] 2020―Jul―17 Body temperature and host species preferences of SARS-CoV-2 Chika Edward Uzoigwe
512 [GO] 2020―Jul―10 Incidence of invasive pulmonary aspergillosis among critically ill COVID-19 patients Frederic Lamoth, Emmanouil Glampedakis, Noémie Boillat-Blanco, Mauro Oddo, Jean-Luc Pagani
513 [GO] 2020―Jul―09 Disappearance of antibodies to SARS-CoV-2 in a Covid-19 patient after recovery Anding Liu, Wenjie Wang, Xuecheng Zhao, Xiaoxi Zhou, Dongliang Yang, Mengji Lu, Yongman Lv
514 [GO] 2020―Jul―09 Viral shedding dynamics in asymptomatic and mildly symptomatic patients infected with SARS-CoV-2 Wei Li, Ying-Ying Su, Shen-Shen Zhi, Jian Huang, Chun-Lan Zhuang, Wei-Zhi Bai, et al. (+8)
515 [GO] 2020―Jul―08 Vertical transmission and materno-fetal outcomes in 13 patients with COVID-19 Sophie Masmejan, Léo Pomar, Guillaume Favre, Alice Panchaud, Eric Giannoni, Gilbert Greub, David Baud
516 [GO] 2020―Jul―08 Lack of sensitivity of an IVD/CE-labeled kit targeting the S gene for detection of SARS-CoV-2 Lucie-Marie Matzkies, Eva Leitner, Evelyn Stelzl, Karoline Assig, Michael Bozic, David Siebenhofer, et al. (+3)
517 [GO] 2020―Jul―03 Reduction in healthcare-associated respiratory viral infections during a COVID-19 outbreak Liang En Wee, Edwin Philip Conceicao, Xiang Ying Jean Sim, Kwan Ki Karrie Ko, Moi Lin Ling, Indumathi Venkatachalam
518 [GO] 2020―Jul―03 Inhale, then exhale: start afresh to diagnose SARS-CoV-2 by non-invasive face mask sampling technique Kanaujia Rimjhim, Biswal Manisha, Angrup Archana, Pallab Ray
519 [GO] 2020―Jul―02 Predictors of progression from moderate to severe COVID-19: a retrospective cohort Biao Cheng, Jiahao Hu, Xiuran Zuo, Jian Chen, Xiaochao Li, Yuchen Chen, et al. (+3)
520 [GO] 2020―Jun―30 Invasive pulmonary fusariosis in an immunocompetent critically ill patient with severe COVID-19 Corentin Poignon, Marion Blaize, Corinne Vezinet, Alexandre Lampros, Antoine Monsel, Arnaud Fekkar
521 [GO] 2020―Jun―30 COVID-19 network: the response of an Italian reference Institute to research challenges about a new pandemia Alessandra Bandera, Stefano Aliberti, Roberta Gualtierotti, Marina Baldini, Francesco Blasi, Matteo Cesari, et al. (+94)
522 [GO] 2020―Jun―27 Corticosteroid administration for viral pneumonia: COVID-19 and beyond Jia-Wei Yang, Ling Yang, Rong-Guang Luo, Jin-Fu Xu
523 [GO] 2020―Jun―27 Childhood COVID-19: a multi-center retrospective study Zhimin Chen, Lin Tong, Yunlian Zhou, Chunzhen Hua, Wei Wang, Junfen Fu, et al. (+13)
524 [GO] 2020―Jun―27 Bacterial and fungal coinfection among hospitalised patients with COVID-19: A retrospective cohort study in a UK secondary care setting Stephen Hughes, Oliver Troise, Hugo Donaldson, Nabeela Mughal, Luke SP. Moore
525 [GO] 2020―Jun―27 Validation of a commercially available SARS-CoV-2 serological immunoassay Benjamin Meyer, Giulia Torriani, Sabine Yerly, Lena Mazza, Adrien Calame, Isabelle Arm-Vernez, et al. (+13)
526 [GO] 2020―Jun―25 Investigation of a nosocomial outbreak of COVID-19 in a pediatric ward in South Korea: Successful control by early detection and extensive contact tracing with testing Jiwon Jung, Min Jee Hong, Eun Ok Kim, Jina Lee, Mi-Na Kim, Sung-Han Kim
527 [GO] 2020―Jun―25 Clinical characteristics of COVID-19 patients in three consecutive generations of spread in Zhejiang, China Yake Yao, Wenyu Chen, Xiaomai Wu, Linfeng Shen, Lisha Shen, Yiqi Fu, et al. (+4)
528 [GO] 2020―Jun―25 Diagnostic strategies for SARS-CoV-2 infection and interpretation of microbiological results Giorgia Caruana, Antony Croxatto, Alix T. Coste, Onya Opota, Frederic Lamoth, Katia Jaton, Gilbert Greub
529 [GO] 2020―Jun―25 Children and SARS-CoV-2 infection: innocent bystanders…until proven otherwise Marcello Lanari, Angela Chiereghin, Giovanni Battista Biserni, Alessandro Rocca, Maria Carla Re, Tiziana Lazzarotto
530 [GO] 2020―Jun―23 Large-scale implementation of pooled RNA extraction and RT-PCR for SARS-CoV-2 detection Roni Ben-Ami, Agnes Klochendler, Matan Seidel, Tal Sido, Ori Gurel-Gurevich, Moran Yassour, et al. (+88)
531 [GO] 2020―Jun―20 Characteristics of 1,573 healthcare workers who underwent nasopharyngeal swab for SARS-CoV-2 in Milano, Lombardy, Italy Andrea Lombardi, Dario Consonni, Michele Carugno, Giorgio Bozzi, Davide Mangioni, Antonio Muscatello, et al. (+10)
532 [GO] 2020―Jun―18 High rate of pulmonary thromboembolism in patients with SARS-CoV-2 pneumonia Pietro Minuz, Giancarlo Mansueto, Fulvia Mazzaferri, Cristiano Fava, Andrea Dalbeni, Maria Chiara Ambrosetti, et al. (+2)
533 [GO] 2020―Jun―12 Ibuprofen use and clinical outcomes in COVID-19 patients Ehud Rinott, Eran Kozer, Yonatan Shapira, Adina Bar-Haim, Ilan Youngster
534 [GO] 2020―Jun―12 Low risk for SARS-CoV2 symptomatic infection and early complications in pediatric patients during the ongoing CoVID19 epidemics in Lombardy F. Rovida, D. Cereda, S. Novati, A. Licari, A. Triarico, G.L. Marseglia, et al. (+135)
535 [GO] 2020―Jun―09 Suggestions from Cremona, Italy - two months into the pandemic at the frontline of COVID-19 in Europe Angelo Pan, Giorgi-Pierfranceschi Matteo, Bosio Giancarlo, Cammelli Lorenzo, Romanini Laura
536 [GO] 2020―Jun―09 Discrepancy in reports of COVID-19 onset of symptoms: is faulty data being collected? Jacques Choucair, Rami Waked, Gebrael Saliba, Fady Haddad, Elie Haddad, Jennifer Makhoul
537 [GO] 2020―Jun―09 Risk factors for disease progression in mild to moderate COVID-19 patients- a multi-center observational study Yuan Cen, Xian Chen, Ye Shen, Xiao-Hua Zhang, Yu Lei, Cheng Xu, et al. (+6)
538 [GO] 2020―Jun―09 Dramatically improved hand hygiene performance rates at time of coronavirus pandemic Sarah Israel, Kamy Harpaz, Eleonora Radvogin, Carmela Schwartz, Ilana Gross, Haggi Mazeh, et al. (+2)
539 [GO] 2020―Jun―09 Clinical evaluation of serological IgG antibody response on the Abbott Architect for established SARS-CoV-2 infection Ka Lip Chew, Shaun S. Tan, Sharon Saw, Anastacia Pajarillaga, Suzzana Zaine, Candy Khoo, et al. (+4)
540 [GO] 2020―Jun―02 Comparison of diagnostic accuracies of rapid serological tests and ELISA to molecular diagnostics in patients with suspected COVID-19 presenting to the hospital David S.Y. Ong, Stijn J. de Man, Fokke A. Lindeboom, Johannes G.M. Koeleman
541 [GO] 2020―Jun―02 Invasive pulmonary aspergillosis in severe coronavirus disease 2019 pneumonia T. Lahmer, S. Rasch, C. Spinner, F. Geisler, R.M. Schmid, W. Huber
542 [GO] 2020―Jun―02 New onset anosmia and ageusia in adult patients diagnosed with SARS-CoV-2 A. Patel, E. Charani, D. Ariyanayagam, A. Abdulaal, S.J. Denny, N. Mughal, L.S.P. Moore
543 [GO] 2020―Jun―02 Excretion of Sars-Cov-2 in human breastmilk samples Simonetta Costa, Brunella Posteraro, Simona Marchetti, Enrica Tamburrini, Brigida Carducci, Antonio Lanzone, et al. (+5)
544 [GO] 2020―May―28 Diagnostic performance of 7 rapid IgG/IgM antibody tests and the Euroimmun IgA/IgG ELISA in COVID-19 patients Jan Van Elslande, Els Houben, Melissa Depypere, Anouk Brackenier, Stefanie Desmet, Emmanuel André, et al. (+3)
545 [GO] 2020―May―23 Review of trials currently testing treatment and prevention of COVID-19 Paraskevi C. Fragkou, Drifa Belhadi, Nathan Peiffer-Smadja, Charalampos D. Moschopoulos, François-Xavier Lescure, Hannah Janocha, et al. (+6)
546 [GO] 2020―May―23 Thromboprophylaxis for medical inpatients with COVID-19 Michael Dalager-Pedersen, Jacob Bodilsen
547 [GO] 2020―May―23 Correlation between viral RNA shedding and serum antibodies in COVID-19 patients Cheng Cheng Jin, Li Zhu, Chun Gao, Sheng Zhang
548 [GO] 2020―May―22 Anosmia in COVID-19 patients Daniel Hornuss, Berit Lange, Nils Schröter, Siegbert Rieg, Winfried V. Kern, Dirk Wagner
549 [GO] 2020―May―22 SARS-CoV-2 Persisted in Lung Tissue Despite Disappearance in Other Clinical Samples Yi Zhao, Zhaohua Xia, Wenhua Liang, Jianfu Li, Lei Liu, Danxia Huang, et al. (+2)
550 [GO] 2020―May―22 SARS-CoV-2 RNA contamination of inanimate surfaces and virus viability in a health care emergency unit Marta Colaneri, Elena Seminari, Stefano Novati, Erika Asperges, Simona Biscarini, Antonio Piralla, et al. (+163)
551 [GO] 2020―May―16 Safety considerations of chloroquine and hydroxychloroquine in treatment of COVID-19 S. Gevers, M.S.G. Kwa, E. Wijnans, C. van Nieuwkoop
552 [GO] 2020―May―16 Reducing hospital admissions for COVID-19 at a dedicated Screening Centre in Singapore Glorijoy Shi En Tan, Ang Hou, Charmaine Malenab Manauis, John Mingzhou Chua, Christine Qiuhan Gao, Frank Kwang Kiat Ng, et al. (+6)
553 [GO] 2020―May―15 Saliva sample as a non-invasive specimen for the diagnosis of coronavirus disease-2019 (COVID-19): a cross-sectional study Ekawat Pasomsub, Siriorn P. Watcharananan, Kochawan Boonyawat, Pareena Janchompoo, Garanyuta Wongtabtim, Worramin Suksuwan, et al. (+2)
554 [GO] 2020―May―15 COVID-19 Outbreak: the gold rush and the Responsibilities of the scientific community Maria Diletta Pezzani
555 [GO] 2020―May―15 A multiple center clinical evaluation of an ultra-fast single-tube assay for SARS-CoV-2 RNA Ji Wang, Kun Cai, Xiaozhou He, Xinxin Shen, Jinrong Wang, Jun Liu, et al. (+21)
556 [GO] 2020―May―01 Clinical characteristics of asymptomatic and symptomatic patients with mild COVID-19 Gwang-un Kim, Min-Jae Kim, Sang Hyun Ra, Jeongsoo Lee, Seongman Bae, Jiwon Jung, Sung-Han Kim
557 [GO] 2020―May―01 Fangcang shelter hospitals in COVID-19 pandemic: the practice and its significance Lianhan Shang, Jiuyang Xu, Bin Cao
558 [GO] 2020―May―01 Low rate of SARS-CoV-2 spread among health care personnel using ordinary personal protection equipment in a medium-incidence setting Emanuele Durante-Mangoni, Roberto Andini, Lorenzo Bertolino, Ferruccio Mele, Mariano Bernardo, Maria Grimaldi, et al. (+8)
559 [GO] 2020―Apr―30 Balancing evidence and frontline experience in the early phases of the COVID-19 pandemic: current position of the Italian Society of anti-infective therapy (SITA) and the Italian Society of Pulmonology (SIP) Matteo Bassetti, Daniele Roberto Giacobbe, Stefano Aliberti, Emanuela Barisione, Stefano Centanni, Francesco Giuseppe De Rosa, et al. (+11)
560 [GO] 2020―Apr―30 SARS-CoV-2 positivity in a discharged COVID-19 patient: A Case report Jingwen Li, Xi Long, Xi Fang, Qing Zhang, Shaoping Hu, Zhicheng Lin, Nian Xiong
561 [GO] 2020―Apr―30 COVID-19: don’t neglect antimicrobial stewardship principles! Benedikt Huttner, Gaud Catho, José Ramón Pano-Pardo, Céline Pulcini, Jeroen Schouten
562 [GO] 2020―Apr―27 A cluster of COVID-19 cases in a small Italian town: a successful example of contact tracing and swab collection Francesca Valent, Tolinda Gallo, Elena Mazzolini, Corrado Pipan, Assunta Sartor, Maria Merelli, et al. (+4)
563 [GO] 2020―Apr―25 Early diagnosis and rapid isolation: response to COVID-19 outbreak in Korea Kyong Ran Peck
564 [GO] 2020―Apr―25 COVID-19 pandemic - A focused review for clinicians Muge Cevik, Connor Bamford, Antonia Ho
565 [GO] 2020―Apr―25 Umifenovir treatment is not associated with improved outcomes in patients with coronavirus disease 2019: A retrospective study Ningfang Lian, Hansheng Xie, Su Lin, Jiefeng Huang, Jianming Zhao, Qichang Lin
566 [GO] 2020―Apr―21 Clinical microbiology laboratory adaptation to COVID-19 emergency: experience at a large teaching hospital in Rome, Italy B. Posteraro, S. Marchetti, L. Romano, R. Santangelo, G.A. Morandotti, M. Sanguinetti, et al. (+19)
567 [GO] 2020―Apr―15 A report of three COVID-19 cases with prolonged viral RNA detection in anal swabs Yilin Hu, Lisha Shen, Yake Yao, Zheming Xu, Jianying Zhou, Hua Zhou
568 [GO] 2020―Apr―15 Risk factors for disease severity, unimprovement, and mortality of COVID-19 patients in Wuhan, China Jixiang Zhang, Xiaoli Wang, Xuemei Jia, Jiao Li, Ke Hu, Guozhong Chen, et al. (+11)
569 [GO] 2020―Apr―08 Association of COVID-19 infection with pregnancy outcomes in healthcare workers and general women Suliman Khan, Li Jun, Rabeea Siddique, Yanyan Li, Guang Han, Mengzhou Xue, et al. (+2)
570 [GO] 2020―Apr―08 Challenges and issues about organising a hospital to respond to the COVID-19 outbreak: experience from a French reference centre Nathan Peiffer-Smadja, Jean-Christophe Lucet, Gisèle Bendjelloul, Lila Bouadma, Sandrine Gerard, Christophe Choquet, et al. (+8)
571 [GO] 2020―Apr―08 Rapid and visual detection of 2019 novel coronavirus (SARS-CoV-2) by a reverse transcription loop-mediated isothermal amplification assay Chao Yan, Jinghua Cui, Lei Huang, Bing Du, Lu Chen, Guanhua Xue, et al. (+12)
572 [GO] 2020―Apr―04 Clinical characteristics of non-critically ill patients with novel coronavirus infection (COVID-19) in a Fangcang Hospital Xiaobing Wang, Jun Fang, Yue Zhu, Liping Chen, Feng Ding, Rui Zhou, et al. (+5)
573 [GO] 2020―Apr―01 The SARS-CoV-2 epidemic: how the Italian public is being informed G. Antonelli, M.R. Capobianchi, E. Riva
574 [GO] 2020―Mar―28 Molecular characterization of SARS-CoV-2 in the first COVID-19 cluster in France reveals an amino-acid deletion in nsp2 (Asp268Del) Antonin Bal, Grégory Destras, Alexandre Gaymard, Maude Bouscambert-Duchamp, Martine Valette, Vanessa Escuret, et al. (+8)
575 [GO] 2020―Mar―28 COVID-19, SARS and MERS: are they closely related? Nicola Petrosillo, Giulio Viceconte, Onder Ergonul, Giuseppe Ippolito, Eskild Petersen
576 [GO] 2020―Mar―28 Follow-up of the asymptomatic patients with SARS-CoV-2 infection Xian Zhou, Yang Li, Tao Li, Wenhong Zhang
577 [GO] 2020―Mar―27 Molecular characterization of SARS-CoV-2 from the first case of COVID-19 in Italy Maria Rosaria Capobianchi, Martina Rueca, Francesco Messina, Emanuela Giombini, Fabrizio Carletti, Francesca Colavita, et al. (+8)
578 [GO] 2020―Feb―20 First Atypical case of 2019 novel coronavirus in Yan'an, China Wendong Hao, Manxiang Li, Xiaoqi Huang
579 [GO] 2020―Feb―11 Novel coronavirus: how the things are in Wuhan Suliman Khan, Ghulam Nabi, Guang Han, Rabeea Siddique, Shuai Lian, Hongwei Shi, et al. (+3)
 [1] 

579 Results       Page 1


[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.044 sec